Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (18735)
All Articles published online
|
May 21, 2012 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18(19): 2300-2308 [PMID: 22654421 DOI: 10.3748/wjg.v18.i19.2300] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i19/2300.htm |
| Number | Citing Articles |
| 1 |
Matthew D Davidson, Salman R Khetani. Intermittent Starvation Extends the Functional Lifetime of Primary Human Hepatocyte Cultures. Toxicological Sciences 2020; 174(2): 266 doi: 10.1093/toxsci/kfaa003
|
| 2 |
Jiang Zhang, Julia Schewe, Hanwei Li, Marie-Christine Makeschin, Ujjwal M. Mahajan, Alexander L. Gerbes, Christian J. Steib. The effects of hepatic steatosis on thromboxane A2 induced portal hypertension. Gastroenterología y Hepatología 2019; 42(9): 534 doi: 10.1016/j.gastrohep.2019.03.015
|
| 3 |
Geoff Farrell, Jörn M. Schattenberg, Isabelle Leclercq, Matthew M. Yeh, Robert Goldin, Narci Teoh, Detlef Schuppan. Mouse Models of Nonalcoholic Steatohepatitis. Hepatology 2019; 69(5): 2241 doi: 10.1002/hep.30333
|
| 4 |
Helmut Denk, Peter M. Abuja, Kurt Zatloukal. Animal models of NAFLD from the pathologist's point of view. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 929 doi: 10.1016/j.bbadis.2018.04.024
|
| 5 |
Nina Graffmann, Lucas-Sebastian Spitzhorn, Audrey Ncube, Wasco Wruck, James Adjaye. Essential Current Concepts in Stem Cell Biology. Learning Materials in Biosciences 2020; : 189 doi: 10.1007/978-3-030-33923-4_11
|
| 6 |
Lu Han, Stefanie Bittner, Dachuan Dong, Yuan Cortez, Hunter Dulay, Sara Arshad, Wen-Jun Shen, Fredric B. Kraemer, Salman Azhar. Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH). Molecular and Cellular Endocrinology 2019; 498: 110538 doi: 10.1016/j.mce.2019.110538
|
| 7 |
Jing Shao, Luyang Li, Huihui Xu, Lili Yang, Yaoyao Bian, Mingming Fang, Yong Xu. Suv39h2 deficiency ameliorates diet-induced steatosis in mice. Biochemical and Biophysical Research Communications 2017; 485(3): 658 doi: 10.1016/j.bbrc.2017.02.093
|
| 8 |
Nouf Aljobaily, Kelsey Krutsinger, Michael J. Viereckl, Raznin Joly, Bridger Menlove, Brexton Cone, Ailaina Suppes, Yuyan Han. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor. Nutrients 2022; 15(1): 178 doi: 10.3390/nu15010178
|
| 9 |
Manoj Amrutkar, Emmelie Cansby, Esther Nuñez‐Durán, Carlo Pirazzi, Marcus Ståhlman, Elin Stenfeldt, Ulf Smith, Jan Borén, Margit Mahlapuu. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH. The FASEB Journal 2015; 29(4): 1564 doi: 10.1096/fj.14-264937
|
| 10 |
Emmelie Cansby, Elin Magnusson, Esther Nuñez-Durán, Manoj Amrutkar, Matteo Pedrelli, Paolo Parini, Jenny Hoffmann, Marcus Ståhlman, Brian W. Howell, Hanns-Ulrich Marschall, Jan Borén, Margit Mahlapuu. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2018; 38(8): 1723 doi: 10.1161/ATVBAHA.118.311241
|
| 11 |
Nobunao Ikewaki, Gary A. Levy, Gene Kurosawa, Masaru Iwasaki, Vidyasagar D. Dedeepiya, Suryaprakash Vaddi, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel J.K. Abraham. Hepatoprotective Effects of Aureobasidium pullulans Derived β 1,3–1,6 Glucans in a Murine Model of Non-alcoholic Steatohepatitis. Journal of Clinical and Experimental Hepatology 2022; 12(6): 1428 doi: 10.1016/j.jceh.2022.06.008
|
| 12 |
T. Fujii, N. Kuriyama, A. Hayasaki, Y. Iizawa, A. Tanemura, H. Kato, Y. Murata, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji. Recombinant Human Soluble Thrombomodulin Attenuates Hepatic Ischemia and/or Reperfusion Injury by Inhibiting Leukocyte Accumulation in Mice With Normal and Fatty Liver. Transplantation Proceedings 2018; 50(9): 2807 doi: 10.1016/j.transproceed.2018.03.044
|
| 13 |
Inês O. Gonçalves, Emanuel Passos, Sílvia Rocha-Rodrigues, Joan R. Torrella, David Rizo, Estela Santos-Alves, Piero Portincasa, Maria J. Martins, António Ascensão, José Magalhães. Physical exercise antagonizes clinical and anatomical features characterizing Lieber-DeCarli diet-induced obesity and related metabolic disorders. Clinical Nutrition 2015; 34(2): 241 doi: 10.1016/j.clnu.2014.03.010
|
| 14 |
Tina Raselli, Tom Hearn, Annika Wyss, Kirstin Atrott, Alain Peter, Isabelle Frey-Wagner, Marianne R. Spalinger, Ewerton M. Maggio, Andreas W. Sailer, Johannes Schmitt, Philipp Schreiner, Anja Moncsek, Joachim Mertens, Michael Scharl, William J. Griffiths, Marco Bueter, Andreas Geier, Gerhard Rogler, Yuqin Wang, Benjamin Misselwitz. Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis. Journal of Lipid Research 2019; 60(7): 1270 doi: 10.1194/jlr.M093229
|
| 15 |
Yoshihisa Takahashi, Toshio Fukusato. Animal Models for the Study of Human Disease. 2017; : 313 doi: 10.1016/B978-0-12-809468-6.00013-9
|
| 16 |
Elia Angelino, Simone Reano, Michele Ferrara, Emanuela Agosti, Andrea Graziani, Nicoletta Filigheddu. Antifibrotic Activity of Acylated and Unacylated Ghrelin. International Journal of Endocrinology 2015; 2015: 1 doi: 10.1155/2015/385682
|
| 17 |
Phiwayinkosi V. Dludla, Bongani B. Nkambule, Sithandiwe E. Mazibuko-Mbeje, Tawanda M. Nyambuya, Fabio Marcheggiani, Ilenia Cirilli, Khanyisani Ziqubu, Samukelisiwe C. Shabalala, Rabia Johnson, Johan Louw, Elisabetta Damiani, Luca Tiano. N-Acetyl Cysteine Targets Hepatic Lipid Accumulation to Curb Oxidative Stress and Inflammation in NAFLD: A Comprehensive Analysis of the Literature. Antioxidants 2020; 9(12): 1283 doi: 10.3390/antiox9121283
|
| 18 |
Miguel Eugenio Zoubek, Christian Trautwein, Pavel Strnad. Reversal of liver fibrosis: From fiction to reality. Best Practice & Research Clinical Gastroenterology 2017; 31(2): 129 doi: 10.1016/j.bpg.2017.04.005
|
| 19 |
Sang-Hyeok Kim, Suk-Jun Lee, Seung-Man Yu. Study of lipid proton difference evaluation via 9.4T MRI analysis of fatty liver induced by exposure to methionine and choline-deficient (MCD) diet and high-fat diet (HFD) in an animal model. Chemistry and Physics of Lipids 2022; 242: 105164 doi: 10.1016/j.chemphyslip.2021.105164
|
| 20 |
Fatiha Nassir, Okunade L. Adewole, Elizabeth M. Brunt, Nada A. Abumrad. CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice. Journal of Lipid Research 2013; 54(11): 2988 doi: 10.1194/jlr.M037812
|
| 21 |
Charlotte J. Green, Camilla Pramfalk, Karl J. Morten, Leanne Hodson. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. American Journal of Physiology-Endocrinology and Metabolism 2015; 308(1): E1 doi: 10.1152/ajpendo.00192.2014
|
| 22 |
Mengyao Zhao, Xin Shen, Xiaodan Li, Baoli Chen, Liqiang Fan, Quanming Xia, Liming Zhao. Chitooligosaccharide supplementation prevents the development of high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in mice via the inhibition of cluster of differentiation 36 (CD36). Journal of Functional Foods 2019; 57: 7 doi: 10.1016/j.jff.2019.03.048
|
| 23 |
Milena N. Stanković, Dušan Mladenović, Milica Ninković, Ivana Ðuričić, Slađana Šobajić, Bojan Jorgačević, Silvio de Luka, Rada Jesic Vukicevic, Tatjana S. Radosavljević. The Effects ofα-Lipoic Acid on Liver Oxidative Stress and Free Fatty Acid Composition in Methionine–Choline Deficient Diet-Induced NAFLD. Journal of Medicinal Food 2014; 17(2): 254 doi: 10.1089/jmf.2013.0111
|
| 24 |
Lindsey Kennedy, Laura Hargrove, Jennifer Demieville, Jennifer M. Bailey, Wasim Dar, Kishore Polireddy, Qingzheng Chen, Moises I. Nevah Rubin, Amelia Sybenga, Sharon DeMorrow, Fanyin Meng, Lindsey Stockton, Gianfranco Alpini, Heather Francis. Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling. The American Journal of Pathology 2018; 188(3): 600 doi: 10.1016/j.ajpath.2017.11.016
|
| 25 |
Avishek Mandal. Cattle Diseases - Molecular and Biochemical Approach. Veterinary Medicine and Science 2023; 16 doi: 10.5772/intechopen.108151
|
| 26 |
Mohan Patil, Dinesh Thapa, Leon N. Warne, Ricky R. Lareu, Elena Dallerba, Jerome Lian, Massimiliano Massi, Rodrigo Carlessi, Marco Falasca. Chronic metabolic effects of novel gut-oriented small-molecule GPR119 agonists in diet-induced obese mice. Biomedicine & Pharmacotherapy 2024; 181: 117675 doi: 10.1016/j.biopha.2024.117675
|
| 27 |
Gwang-Won Kim, Kyu-Youn Ahn, Yun-Hyeon Kim, Gwang-Woo Jeong. Time-course metabolic changes in high-fat diet-induced obesity rats: A pilot study using hyperpolarized 13C dynamic MRS. Magnetic Resonance Imaging 2016; 34(8): 1199 doi: 10.1016/j.mri.2016.06.002
|
| 28 |
Jennie Ka Ching Lau, Xiang Zhang, Jun Yu. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 139 doi: 10.1007/978-981-10-8684-7_11
|
| 29 |
Mara Caputo, Yeshwant Kurhe, Sima Kumari, Emmelie Cansby, Manoj Amrutkar, Eli Scandalis, Sheri L. Booten, Marcus Ståhlman, Jan Borén, Hanns‐Ulrich Marschall, Mariam Aghajan, Margit Mahlapuu. Silencing of STE20‐type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet‐induced nonalcoholic fatty liver disease. The FASEB Journal 2021; 35(5) doi: 10.1096/fj.202002671RR
|
| 30 |
Jeffrey A. Willy, Sara K. Young, James L. Stevens, Howard C. Masuoka, Ronald C. Wek, Reid Gilmore. CHOP links endoplasmic reticulum stress to NF-κB activation in the pathogenesis of nonalcoholic steatohepatitis. Molecular Biology of the Cell 2015; 26(12): 2190 doi: 10.1091/mbc.E15-01-0036
|
| 31 |
Dipali Sharma, Neeraj K. Saxena. Murine Models, Energy Balance, and Cancer. Energy Balance and Cancer 2015; 10: 247 doi: 10.1007/978-3-319-16733-6_12
|
| 32 |
Christopher Scott, Rebecca Stokes, Kuan Minn Cha, Andrew Clouston, Mohammed Eslam, Mayda Metwally, Michael M. Swarbrick, Jacob George, Jenny E. Gunton, Marcia B. Aguila. Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis. PLOS ONE 2019; 14(12): e0225332 doi: 10.1371/journal.pone.0225332
|
| 33 |
Qian Zhang, Zhi-Yong Qian, Peng-Hui Zhou, Xiao-li Zhou, Da-Long Zhang, Ning He, Jing Zhang, Ying-Hua Liu, Qing Gu. Effects of oral selenium and magnesium co-supplementation on lipid metabolism, antioxidative status, histopathological lesions, and related gene expression in rats fed a high-fat diet. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0815-4
|
| 34 |
Mei Chung, Jiantao Ma, Kamal Patel, Samantha Berger, Joseph Lau, Alice H Lichtenstein. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis , , ,. The American Journal of Clinical Nutrition 2014; 100(3): 833 doi: 10.3945/ajcn.114.086314
|
| 35 |
Supriya Sen, Magda Langiewicz, Hassan Jumaa, Nicholas J.G. Webster. Deletion of serine/arginine‐rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice. Hepatology 2015; 61(1): 171 doi: 10.1002/hep.27380
|
| 36 |
Alifia Mukti Fajrani, Mohamad Sulchan, Siti Fatimah Muis, Hery Djagat Purnomo, Kis Djamiatun, Vega Karlowee, Martha Ardiaria. Effect of black garlic on visceral fat, oxidative stress and insulin resistance in nonalcoholic fatty liver disease rats. Nutrition & Food Science
2021; 51(7): 1084 doi: 10.1108/NFS-11-2020-0439
|
| 37 |
Lianxin Peng, Qu Zhang, Yanhong Zhang, Zhendong Yao, Panpan Song, Lijuan Wei, Gang Zhao, Zhuyun Yan. Effect of tartary buckwheat, rutin, and quercetin on lipid metabolism in rats during high dietary fat intake. Food Science & Nutrition 2020; 8(1): 199 doi: 10.1002/fsn3.1291
|
| 38 |
Rory P. Cunningham, Natalie Porat-Shliom. Liver Zonation – Revisiting Old Questions With New Technologies. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.732929
|
| 39 |
Radina Kostadinova, Simon Ströbel, Li Chen, Katia Fiaschetti‑Egli, Jana Gadient, Agnieszka Pawlowska, Louis Petitjean, Manuela Bieri, Eva Thoma, Mathieu Petitjean. Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55438-2
|
| 40 |
Alba Garcimartín, M Elvira López-Oliva, Jorge A Sántos-López, Rosa A García-Fernández, Adrián Macho-González, Sara Bastida, Juana Benedí, Francisco J Sánchez-Muniz. Silicon Alleviates Nonalcoholic Steatohepatitis by Reducing Apoptosis in Aged Wistar Rats Fed a High–Saturated Fat, High-Cholesterol Diet. The Journal of Nutrition 2017; 147(6): 1104 doi: 10.3945/jn.116.243204
|
| 41 |
Joe L. Rowles, Aiguo Han, Rita J. Miller, Jamie R. Kelly, Catherine C. Applegate, Matthew A. Wallig, William D. O’Brien, John W. Erdman. Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL/6J mice: monitored by a novel quantitative ultrasound (QUS) method. Nutrition Research 2019; 63: 95 doi: 10.1016/j.nutres.2018.12.003
|
| 42 |
Chieko Ejima, Haruna Kuroda, Sonoko Ishizaki. A novel diet‐induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis. Physiological Reports 2016; 4(21) doi: 10.14814/phy2.13016
|
| 43 |
Jie Zhou, Chi-Tang Ho, Piaopiao Long, Qilu Meng, Liang Zhang, Xiaochun Wan. Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease. Journal of Agricultural and Food Chemistry 2019; 67(19): 5306 doi: 10.1021/acs.jafc.8b05032
|
| 44 |
Safaa H. Mohamed, Abdelaaty A. Shahat, Mohamed R. Mohamed, Wagdy K. B. Khalil, Ahmed M. Salem, Abdel Razik H. Farrag, Hanaa H. Ahmed. Camellia sinesis leaves extract ameliorates high fat diet-induced nonalcoholic steatohepatitis in rats: analysis of potential mechanisms. Journal of Pharmaceutical Investigation 2021; 51(2): 183 doi: 10.1007/s40005-020-00500-0
|
| 45 |
Ioannis Katsaros, Maria Sotiropoulou, Michail Vailas, Emmanouil Ioannis Kapetanakis, Georgia Valsami, Alexandra Tsaroucha, Dimitrios Schizas. Quercetin’s Potential in MASLD: Investigating the Role of Autophagy and Key Molecular Pathways in Liver Steatosis and Inflammation. Nutrients 2024; 16(22): 3789 doi: 10.3390/nu16223789
|
| 46 |
Ceri‐Anne E. Suurmond, Soufian Lasli, Floor W. van den Dolder, Aly Ung, Han‐Jun Kim, Praveen Bandaru, KangJu Lee, Hyun‐Jong Cho, Samad Ahadian, Nureddin Ashammakhi, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer Cells. Advanced Healthcare Materials 2019; 8(24) doi: 10.1002/adhm.201901379
|
| 47 |
Victoria Sid, Yaw L. Siow, Karmin O. Role of folate in nonalcoholic fatty liver disease. Canadian Journal of Physiology and Pharmacology 2017; 95(10): 1141 doi: 10.1139/cjpp-2016-0681
|
| 48 |
Srinivas Pittala, Yakov Krelin, Yael Kuperman, Varda Shoshan-Barmatz. A Mitochondrial VDAC1-Based Peptide Greatly Suppresses Steatosis and NASH-Associated Pathologies in a Mouse Model. Molecular Therapy 2019; 27(10): 1848 doi: 10.1016/j.ymthe.2019.06.017
|
| 49 |
Tian Shen, Bilin Xu, Tao Lei, Lin Chen, Cuiping Zhang, Zhenhua Ni. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6554
|
| 50 |
Mi-Ra Lee, Kwang Park, Jin Ma. Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet. Nutrients 2017; 10(1): 20 doi: 10.3390/nu10010020
|
| 51 |
Ana L. Gomes, Ana Teijeiro, Stefan Burén, Krishna S. Tummala, Mahmut Yilmaz, Ari Waisman, Jean-Philippe Theurillat, Cristian Perna, Nabil Djouder. Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma. Cancer Cell 2016; 30(1): 161 doi: 10.1016/j.ccell.2016.05.020
|
| 52 |
Tong-shuo Zhang, Hua-lei Qin, Tong Wang, Hai-tao Li, Hai Li, Shi-hai Xia, Xiao-hui Xiang. Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review. SpringerPlus 2015; 4(1) doi: 10.1186/s40064-015-1542-1
|
| 53 |
Yoshihisa Takahashi, Keiichiro Sugimoto, Yurie Soejima, Arisa Kumagai, Tatsuki Koeda, Aiko Shojo, Kazuya Nakagawa, Naoki Harada, Ryoichi Yamaji, Hiroshi Inui, Toshikazu Yamanouchi, Toshio Fukusato. Inhibitory Effects of Eucalyptus and Banaba Leaf Extracts on Nonalcoholic Steatohepatitis Induced by a High-Fructose/High-Glucose Diet in Rats. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/296207
|
| 54 |
Mai Kato, Momoka Yamaguchi, Akira Ooka, Ryota Takahashi, Takuji Suzuki, Keita Onoda, Yuko Yoshikawa, Yuta Tsunematsu, Michio Sato, Yasukiyo Yoshioka, Miki Igarashi, Sumio Hayakawa, Kumiko Shoji, Yutaka Shoji, Tomohisa Ishikawa, Kenji Watanabe, Noriyuki Miyoshi. Non-target GC–MS analyses of fecal VOCs in NASH-hepatocellular carcinoma model STAM mice. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-36091-7
|
| 55 |
Wen-Lung Ma, Hsueh-Chou Lai, Shuyuan Yeh, Xiujun Cai, Chawnshang Chang. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocrine-Related Cancer 2014; 21(3): R165 doi: 10.1530/ERC-13-0283
|
| 56 |
Enxiang Zhang, Shutao Yin, Xinhua Song, Lihong Fan, Hongbo Hu. Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway. Scientific Reports 2016; 6(1) doi: 10.1038/srep38138
|
| 57 |
Md. Abdul Hye Khan, Jurema Schmidt, Anna Stavniichuk, John D. Imig, Daniel Merk. A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice. Biochemical Pharmacology 2019; 166: 212 doi: 10.1016/j.bcp.2019.05.023
|
| 58 |
Gonzalo Torres-Villalobos, Nashla Hamdan-Pérez, Armando R. Tovar, Guillermo Ordaz-Nava, Braulio Martínez-Benítez, Iván Torre-Villalvazo, Sofía Morán-Ramos, Andrea Díaz-Villaseñor, Lilia G. Noriega, Marcia Hiriart, Roberto Medina-Santillán, María del Carmen Castillo-Hernandez, Nahum Méndez-Sánchez, Misael Uribe, Nimbe Torres. Combined high-fat diet and sustained high sucrose consumption promotes NAFLD in a murine model. Annals of Hepatology 2015; 14(4): 540 doi: 10.1016/S1665-2681(19)31176-7
|
| 59 |
Yang Zhang, Qiangman Wei, Xue Geng, Guoliang Fang. Long-Term Aerobic Exercise Enhances Hepatoprotection in MAFLD by Modulating Exosomal miR-324 via ROCK1. Metabolites 2024; 14(12): 692 doi: 10.3390/metabo14120692
|
| 60 |
Torsten Schröder, David Kucharczyk, Florian Bär, René Pagel, Stefanie Derer, Sebastian Torben Jendrek, Annika Sünderhauf, Ann-Kathrin Brethack, Misa Hirose, Steffen Möller, Axel Künstner, Julia Bischof, Imke Weyers, Jörg Heeren, Dirk Koczan, Sebastian Michael Schmid, Senad Divanovic, Daniel Aaron Giles, Jerzy Adamski, Klaus Fellermann, Hendrik Lehnert, Jörg Köhl, Saleh Ibrahim, Christian Sina. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. Molecular Metabolism 2016; 5(4): 283 doi: 10.1016/j.molmet.2016.01.010
|
| 61 |
Nanshuo Cai, Yifan Wu, Yan Huang. Induction of Accelerated Aging in a Mouse Model. Cells 2022; 11(9): 1418 doi: 10.3390/cells11091418
|
| 62 |
Momoko Hayashi, Yoshibumi Kuwabara, Kuniji Ito, Yoshiaki Hojo, Fumiaki Arai, Kazuki Kamijima, Masakazu Takeiri, Xiaojing Wang, Pan Diao, Jun Nakayama, Naoki Tanaka. Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis. Biomedicines 2023; 11(2): 384 doi: 10.3390/biomedicines11020384
|
| 63 |
Yousra M. Ezz-Eldin, Mohamed G. Ewees, Amany A. Azouz, Marwa M. Khalaf. Investigating the tamoxifen/high-fat diet synergy: a promising paradigm for nonalcoholic steatohepatitis induction in a rat model. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(11): 9067 doi: 10.1007/s00210-024-03192-7
|
| 64 |
Jake P. Mann, Robert K. Semple, Matthew J. Armstrong. How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?. Frontiers in Endocrinology 2016; 7 doi: 10.3389/fendo.2016.00145
|
| 65 |
Masao Yamasaki, Yusuke Matsuyama, Rintaro Hayasegawa, Kensaku Hamada, Kazuo Nishiyama, Takanori Kai, Kozo Kamenaga, Teruaki Arakawa, Hiroyuki Tari, Yoshio Shimizu, Yasushi Matsuura, Chizuko Yukizaki. Blueberry (<i>Vaccinium virgatum</i> Aiton) Leaf Infusion Ameliorates Insulin Resistance in Mice Fed a High-fat, High-sucrose Diet. Food Science and Technology Research 2015; 21(6): 827 doi: 10.3136/fstr.21.827
|
| 66 |
Begoña Lavin, Thomas R. Eykyn, Alkystis Phinikaridou, Aline Xavier, Shravan Kumar, Xabier Buqué, Patricia Aspichueta, Carlos Sing‐Long, Marco Arrese, René M. Botnar, Marcelo E. Andia. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. NMR in Biomedicine 2023; 36(8) doi: 10.1002/nbm.4932
|
| 67 |
James E. Klaunig, Xilin Li, Zemin Wang. Role of xenobiotics in the induction and progression of fatty liver disease. Toxicology Research 2018; 7(4): 664 doi: 10.1039/c7tx00326a
|
| 68 |
Zoe Hall, Nicholas J. Bond, Tom Ashmore, Francis Sanders, Zsuzsanna Ament, Xinzhu Wang, Andrew J. Murray, Elena Bellafante, Sam Virtue, Antonio Vidal‐Puig, Michael Allison, Susan E. Davies, Albert Koulman, Michele Vacca, Julian L. Griffin. Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hepatology 2017; 65(4): 1165 doi: 10.1002/hep.28953
|
| 69 |
Aleksandra Aizenshtadt, Chencheng Wang, Shadab Abadpour, Pedro Duarte Menezes, Ingrid Wilhelmsen, Andrea Dalmao‐Fernandez, Justyna Stokowiec, Alexey Golovin, Mads Johnsen, Thomas M. D. Combriat, Hanne Røberg‐Larsen, Nikolaj Gadegaard, Hanne Scholz, Mathias Busek, Stefan J. K. Krauss. Pump‐Less, Recirculating Organ‐on‐Chip (rOoC) Platform to Model the Metabolic Crosstalk between Islets and Liver. Advanced Healthcare Materials 2024; 13(13) doi: 10.1002/adhm.202303785
|
| 70 |
Alexandra Collin de l’Hortet, Kazuki Takeishi, Jorge Guzman-Lepe, Kazutoyo Morita, Abhinav Achreja, Branimir Popovic, Yang Wang, Kan Handa, Anjali Mittal, Noah Meurs, Ziwen Zhu, Frank Weinberg, Michael Salomon, Ira J. Fox, Chu-Xia Deng, Deepak Nagrath, Alejandro Soto-Gutierrez. Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism. Cell Metabolism 2019; 30(2): 385 doi: 10.1016/j.cmet.2019.06.017
|
| 71 |
Xin Shen, Xinyi Liang, Xiaoguo Ji, Jiangshan You, Xinye Zhuang, Yudong Song, Hao Yin, Mengyao Zhao, Liming Zhao. CD36 and DGAT2 facilitate the lipid-lowering effect of chitooligosaccharides via fatty acid intake and triglyceride synthesis signaling. Food & Function 2021; 12(18): 8681 doi: 10.1039/D1FO01472B
|
| 72 |
Yoshihisa Takahashi, Yurie Soejima, Arisa Kumagai, Masato Watanabe, Hiroshi Uozaki, Toshio Fukusato, Kalpana Ghoshal. Inhibitory Effects of Japanese Herbal Medicines Sho-saiko-to and Juzen-taiho-to on Nonalcoholic Steatohepatitis in Mice. PLoS ONE 2014; 9(1): e87279 doi: 10.1371/journal.pone.0087279
|
| 73 |
Takahiro Okuno, Anna Kakehashi, Naomi Ishii, Masaki Fujioka, Min Gi, Hideki Wanibuchi. mTOR Activation in Liver Tumors Is Associated with Metabolic Syndrome and Non-Alcoholic Steatohepatitis in Both Mouse Models and Humans. Cancers 2018; 10(12): 465 doi: 10.3390/cancers10120465
|
| 74 |
Jiabao Liao, Yongjun Cao, Jie Zhao, Bolun Yu, Yuming Wang, Wenting Li, Hanzhou Li, Shuquan Lv, Weibo Wen, Huantian Cui, Yao Chen. Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver. Phytomedicine 2023; 118: 154937 doi: 10.1016/j.phymed.2023.154937
|
| 75 |
Christoph G Dietrich, Oliver Götze, Andreas Geier. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World Journal of Gastroenterology 2016; 22(1): 72-88 doi: 10.3748/wjg.v22.i1.72
|
| 76 |
Yoshihisa Takahashi, Yurie Soejima, Toshio Fukusato. Integrative Weight Management. 2014; : 61 doi: 10.1007/978-1-4939-0548-5_6
|
| 77 |
Koichi Tsuneyama, Kazuchika Nishitsuji, Minoru Matsumoto, Tomoko Kobayashi, Yuki Morimoto, Takaaki Tsunematsu, Hirohisa Ogawa. Animal models for analyzing metabolic syndrome‐associated liver diseases. Pathology International 2017; 67(11): 539 doi: 10.1111/pin.12600
|
| 78 |
Ciarán P Fisher, Andrzej M Kierzek, Nick J Plant, J Bernadette Moore. Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(41): 15070-15078 doi: 10.3748/wjg.v20.i41.15070
|
| 79 |
Kyohei Yasuno, Kazuyoshi Kumagai, Takuma Iguchi, Yoshimi Tsuchiya, Kiyonori Kai, Kazuhiko Mori. DS-7250, a Diacylglycerol Acyltransferase 1 Inhibitor, Enhances Hepatic Steatosis in Zucker Fatty Rats via Upregulation of Fatty Acid Synthesis. Toxicologic Pathology 2018; 46(3): 302 doi: 10.1177/0192623318765909
|
| 80 |
Sonja Marinović, Maja Lenartić, Karlo Mladenić, Marko Šestan, Inga Kavazović, Ante Benić, Mia Krapić, Lukas Rindlisbacher, Maja Cokarić Brdovčak, Colin Sparano, Gioana Litscher, Tamara Turk Wensveen, Ivana Mikolašević, Dora Fučkar Čupić, Lidija Bilić-Zulle, Aleksander Steinle, Ari Waisman, Adrian Hayday, Sonia Tugues, Burkhard Becher, Bojan Polić, Felix M. Wensveen. NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis. Science Immunology 2023; 8(87) doi: 10.1126/sciimmunol.add1599
|
| 81 |
Siham N.K. Al-Shaaibi, Mostafa I. Waly, Lyutha Al-Subhi, Mohamed H. Tageldin, Nada M. Al-Balushi, Mohammad Shafiur Rahman. Ameliorative Effects of Pomegranate Peel Extract against Dietary-Induced Nonalcoholic Fatty Liver in Rats. Preventive Nutrition and Food Science 2016; 21(1): 14 doi: 10.3746/pnf.2016.21.1.14
|
| 82 |
Mi-Bo Kim, Yoojin Lee, Minkyung Bae, Hyunju Kang, Tho X. Pham, Siqi Hu, Ji-Young Lee, Young-Ki Park. Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis. The Journal of Nutritional Biochemistry 2020; 85: 108463 doi: 10.1016/j.jnutbio.2020.108463
|
| 83 |
T. SAITO, M. MURAMATSU, Y. ISHII, Y. SAIGO, T. KONUMA, Y. TORINIWA, K. MIYAJIMA, T. OHTA. Pathophysiological Analysis of the Progression of Hepatic Lesions in STAM Mice. Physiological Research 2017; : 791 doi: 10.33549/physiolres.933592
|
| 84 |
Sumati Rohilla, Ankita Awasthi, Savneet Kaur, Rekha Puria. Evolutionary conservation of long non-coding RNAs in non-alcoholic fatty liver disease. Life Sciences 2021; 264: 118560 doi: 10.1016/j.lfs.2020.118560
|
| 85 |
Felipe N. Camargo, Sandro L. Matos, Layanne C. C. Araujo, Carla R. O. Carvalho, Andressa G. Amaral, João Paulo Camporez. Western Diet-Fed ApoE Knockout Male Mice as an Experimental Model of Non-Alcoholic Steatohepatitis. Current Issues in Molecular Biology 2022; 44(10): 4692 doi: 10.3390/cimb44100320
|
| 86 |
Adriana Carino, Sabrina Cipriani, Silvia Marchianò, Michele Biagioli, Chiara Santorelli, Annibale Donini, Angela Zampella, Maria Chiara Monti, Stefano Fiorucci. BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis. Scientific Reports 2017; 7(1) doi: 10.1038/srep42801
|
| 87 |
Vera Lede, Andrej Meusel, Antje Garten, Yulia Popkova, Melanie Penke, Christin Franke, Albert Ricken, Angela Schulz, Wieland Kiess, Daniel Huster, Torsten Schöneberg, Jürgen Schiller, Yanqiao Zhang. Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor. PLOS ONE 2017; 12(2): e0172000 doi: 10.1371/journal.pone.0172000
|
| 88 |
Mahak Arora, Nikolina Kutinová Canová, Hassan Farghali. mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis. European Journal of Pharmacology 2022; 921: 174857 doi: 10.1016/j.ejphar.2022.174857
|
| 89 |
Tianpeng Zhang, Junjie Hu, Xiaomei Wang, Xiaoling Zhao, Zhuoyu Li, Junqi Niu, Clifford J. Steer, Guohua Zheng, Guisheng Song. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway. Journal of Hepatology 2019; 70(1): 87 doi: 10.1016/j.jhep.2018.08.026
|
| 90 |
Richard Matthew Atkins, Meghan Pantalia, Christopher Skaggs, Alexander Ku Lau, Muhammad Bilal Mahmood, Muhammad Mubeen Anwar, Lindsay Barron, Bonnie Eby, Usman Khan, Leo Tsiokas, Kai Lau. Normotensive metabolic syndrome in Transient Receptor Potential Canonical Channel type 1 Trpc1−/− mice.. Biology Open 2024; 13(7) doi: 10.1242/bio.060280
|
| 91 |
Ferah Armutcu, Sumeyya Akyol, Fatma Ucar, Serpil Erdogan, Omer Akyol. . Advances in Clinical Chemistry 2013; 61: 67 doi: 10.1016/B978-0-12-407680-8.00004-X
|
| 92 |
Dalton S. Graham, Gang Liu, Ailar Arasteh, Xiao-Ming Yin, Shengmin Yan, Nobuyuki Takahashi. Ability of high fat diet to induce liver pathology correlates with the level of linoleic acid and Vitamin E in the diet. PLOS ONE 2023; 18(6): e0286726 doi: 10.1371/journal.pone.0286726
|
| 93 |
Yuichiro Amano, Fumi Shimizu, Hironobu Yasuno, Ayako Harada, Shuntarou Tsuchiya, Osamu Isono, Hiroshi Nagabukuro, Ryuichi Tozawa. Non‐alcoholic steatohepatitis‐associated hepatic fibrosis and hepatocellular carcinoma in a combined mouse model of genetic modification and dietary challenge. Hepatology Research 2017; 47(1): 103 doi: 10.1111/hepr.12709
|
| 94 |
Mariana Luisa Verdelho Moutinho Machado, Anna Mae Diehl. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 121 doi: 10.1007/978-3-319-20538-0_6
|
| 95 |
Su-Jung Cho, Un Ju Jung, Hye-Jin Kim, Ri Ryu, Jae Young Ryoo, Byoung Seok Moon, Myung-Sook Choi. Effects of the Combined Extracts of Grape Pomace and Omija Fruit on Hyperglycemia and Adiposity in Type 2 Diabetic Mice. Preventive Nutrition and Food Science 2015; 20(2): 94 doi: 10.3746/pnf.2015.20.2.94
|
| 96 |
Shuntarou Tsuchiya, Yuichiro Amano, Osamu Isono, Mayumi Imai, Fumi Shimizu, Mari Asada, Shigemitsu Imai, Ayako Harada, Yoshitaka Yasuhara, Ryuichi Tozawa, Hiroshi Nagabukuro. Pharmacological evaluation of pioglitazone and candesartan cilexetil in a novel mouse model of non‐alcoholic steatohepatitis, modified choline‐deficient, amino acid‐defined diet fed low‐density lipoprotein receptor knockout mice. Hepatology Research 2017; 47(6): 584 doi: 10.1111/hepr.12773
|
| 97 |
Nina Graffmann, Sarah Ring, Marie-Ann Kawala, Wasco Wruck, Audrey Ncube, Hans-Ingo Trompeter, James Adjaye. Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha. Stem Cells and Development 2016; 25(15): 1119 doi: 10.1089/scd.2015.0383
|
| 98 |
Timothy E. Thayer, Christian L. Lino Cardenas, Trejeeve Martyn, Christopher J. Nicholson, Lisa Traeger, Florian Wunderer, Charles Slocum, Haakon Sigurslid, Hannah R. Shakartzi, Caitlin O’Rourke, Georgia Shelton, Mary D. Buswell, Hanna Barnes, Leif R. Neitzel, Clara D. Ledsky, Jason Pingcheng Li, Megan F. Burke, Eric Farber-Eger, Daniel S. Perrien, Ravindra Kumar, Kathleen E. Corey, Quinn S. Wells, Kenneth D. Bloch, Charles C. Hong, Donald B. Bloch, Rajeev Malhotra. The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66770-8
|
| 99 |
Yoshitaka Kondo, Goji Hasegawa, Hiroshi Okada, Takafumi Senmaru, Michiaki Fukui, Naoto Nakamura, Morio Sawada, Jo Kitawaki, Takeshi Okanoue, Yuki Kishimoto, Akiko Amano, Naoki Maruyama, Hiroshi Obayashi, Akihito Ishigami, Anna Alisi. Leprdb/db Mice with Senescence Marker Protein-30 Knockout (Leprdb/dbSmp30Y/−) Exhibit Increases in Small Dense-LDL and Severe Fatty Liver Despite Being Fed a Standard Diet. PLoS ONE 2013; 8(6): e65698 doi: 10.1371/journal.pone.0065698
|
| 100 |
Laura G. Di Pasqua, Clarissa Berardo, Vittoria Rizzo, Plinio Richelmi, Anna Cleta Croce, Mariapia Vairetti, Andrea Ferrigno. MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters. Molecular and Cellular Biochemistry 2016; 419(1-2): 147 doi: 10.1007/s11010-016-2758-2
|
| 101 |
Yeon Ji Chae, Dae Won Jun, Waqar Khalid Saeed, Hyeon Tae Kang, Ju Hee Oh, Seung Min Lee, Kiseok Jang. Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver Studies. Journal of Korean Medical Science 2019; 34(2) doi: 10.3346/jkms.2019.34.e14
|
| 102 |
Banrida Wahlang, Juliane I. Beier, Heather B. Clair, Heather J. Bellis-Jones, K. Cameron Falkner, Craig J. McClain, Matt C. Cave. Toxicant-associated Steatohepatitis. Toxicologic Pathology 2013; 41(2): 343 doi: 10.1177/0192623312468517
|
| 103 |
Masashi Miyao, Hirokazu Kotani, Tokiko Ishida, Chihiro Kawai, Sho Manabe, Hitoshi Abiru, Keiji Tamaki. Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. Laboratory Investigation 2015; 95(10): 1130 doi: 10.1038/labinvest.2015.95
|
| 104 |
Dries Bauters, Pieter Spincemaille, Lotte Geys, David Cassiman, Pieter Vermeersch, Pierre Bedossa, Ilse Scroyen, Henri R. Lijnen. ADAMTS5 deficiency protects against non‐alcoholic steatohepatitis in obesity. Liver International 2016; 36(12): 1848 doi: 10.1111/liv.13181
|
| 105 |
Azza S. M. Awad, Ekram N. Abd Al Haleem, Wesam M. El-Bakly, Mohie A. Sherief. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(4): 381 doi: 10.1007/s00210-015-1207-1
|
| 106 |
Fontini Tania Mitsinikos, Denise Chac, Nicholas Schillingford, R. William DePaolo. Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease. Gut Microbes 2020; 12(1): 1792256 doi: 10.1080/19490976.2020.1792256
|
| 107 |
Martine C. Morrison, Lars Verschuren, Kanita Salic, Joanne Verheij, Aswin Menke, Peter Y. Wielinga, Marta Iruarrizaga‐Lejarreta, Laurent Gole, Wei‐Miao Yu, Scott Turner, Martien P.M. Caspers, Ibon Martínez‐Arranz, Elsbet Pieterman, Reinout Stoop, Arianne van Koppen, Anita M. van den Hoek, José M. Mato, Roeland Hanemaaijer, Cristina Alonso, Robert Kleemann. Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice. Hepatology Communications 2018; 2(12): 1513 doi: 10.1002/hep4.1270
|
| 108 |
Shumin Sun, Fumiaki Hanzawa, Daeun Kim, Miki Umeki, Syunsuke Nakajima, Kumiko Sakai, Saiko Ikeda, Satoshi Mochizuki, Hiroaki Oda. Circadian rhythm–dependent induction of hepatic lipogenic gene expression in rats fed a high-sucrose diet. Journal of Biological Chemistry 2019; 294(42): 15206 doi: 10.1074/jbc.RA119.010328
|
| 109 |
Young-Sun Lee, Ekihiro Seki. In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations. Cellular and Molecular Gastroenterology and Hepatology 2023; 16(3): 355 doi: 10.1016/j.jcmgh.2023.05.010
|
| 110 |
Da Eun Kim, Bo Yoon Chang, Byeong Min Jeon, Jong In Baek, Sun Chang Kim, Sung Yeon Kim. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway. International Journal of Molecular Sciences 2020; 21(12): 4534 doi: 10.3390/ijms21124534
|
| 111 |
Hiroshi MIYAZAKI, Kimitaka TAKITANI, Maki KOH, Akiko INOUE, Kanta KISHI, Hiroshi TAMAI. Retinol Status and Expression of Retinol-Related Proteins in Methionine-Choline Deficient Rats. Journal of Nutritional Science and Vitaminology 2014; 60(2): 78 doi: 10.3177/jnsv.60.78
|
| 112 |
Maximilian Joseph Brol, Stella Georgiou, Ditlev Nytoft Rasmussen, Cristina Ortiz, Sabine Klein, Robert Schierwagen, Frank Erhard Uschner, Larissa Eberle, Sönke Detlefsen, Vasiliki I. Pantazopoulou, Maja Thiele, Vasiliki Filippa, Sandra Torres, Ema Anastasiadou, Aleksander Krag, Jonel Trebicka. Effects of Ethanol Feeding in Early-Stage NAFLD Mice Induced by Western Diet. Livers 2021; 1(1): 27 doi: 10.3390/livers1010003
|
| 113 |
XIANG WANG, QIAOHUA REN, TAO WU, YONG GUO, YONG LIANG, SUBO LIU. Ezetimibe prevents the development of non-alcoholic fatty liver disease induced by high-fat diet in C57BL/6J mice. Molecular Medicine Reports 2014; 10(6): 2917 doi: 10.3892/mmr.2014.2623
|
| 114 |
Mariana Verdelho Machado, Helena Cortez-Pinto. Leptin in the treatment of lipodystrophy-associated nonalcoholic fatty liver disease: are we there already?. Expert Review of Gastroenterology & Hepatology 2013; 7(6): 513 doi: 10.1586/17474124.2013.814903
|
| 115 |
Hayato Nakagawa. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis. World Journal of Hepatology 2015; 7(17): 2110-2118 doi: 10.4254/wjh.v7.i17.2110
|
| 116 |
Adile Merve BAKİ, Pervin VURAL, Abdurrahman Fatih AYDIN, Merva SOLUK TEKKEŞİN, Semra DOĞRU-ABBASOĞLU, Müjdat UYSAL. Effect of α-lipoic acid and N-acetylcysteine on liver oxidative stress, preneoplastic lesions induced by diethylnitrosamine plus high-fat diet. Archives of Clinical and Experimental Medicine 2021; 6(1): 1 doi: 10.25000/acem.830126
|
| 117 |
Ming-xia Liu, Man Gao, Chun-zhu Li, Cun-zhi Yu, Hong Yan, Chun Peng, Yu Li, Cheng-gang Li, Ze-long Ma, Yang Zhao, Meng-fan Pu, Ling-ling Miao, Xin-ming Qi, Jin Ren. Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis. Acta Pharmacologica Sinica 2017; 38(5): 660 doi: 10.1038/aps.2016.158
|
| 118 |
Maria Martin-Grau, Vannina G Marrachelli, Daniel Monleon. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?. World Journal of Hepatology 2022; 14(2): 304-318 doi: 10.4254/wjh.v14.i2.304
|
| 119 |
Jacques Delarue, Jean-Paul Lallès. Rôles de l’intestin et du foie dans la progression de la stéatopathie métabolique et sa modulation par les acides gras polyinsaturés à longue chaîne n-3. Cahiers de Nutrition et de Diététique 2016; 51(6): 283 doi: 10.1016/j.cnd.2016.09.002
|
| 120 |
Xiaofang Jia, Hisao Naito, Kazuya Kitamori, Husna Yetti, Tamie Nakajima. Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults. 2015; : 85 doi: 10.1016/B978-0-12-418680-4.00009-9
|
| 121 |
Durgesh Kumar Dwivedi, G. B. Jena. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2020; 393(4): 705 doi: 10.1007/s00210-019-01773-5
|
| 122 |
Donald B Jump, Christopher M Depner, Sasmita Tripathy, Kelli A Lytle. Potential for Dietary ω-3 Fatty Acids to Prevent Nonalcoholic Fatty Liver Disease and Reduce the Risk of Primary Liver Cancer. Advances in Nutrition 2015; 6(6): 694 doi: 10.3945/an.115.009423
|
| 123 |
Arunraj Namachivayam, Abilash Valsala Gopalakrishnan. A review on molecular mechanism of alcoholic liver disease. Life Sciences 2021; 274: 119328 doi: 10.1016/j.lfs.2021.119328
|
| 124 |
Yi-Syuan Lai, Wan-Ching Lee, Yu-En Lin, Chi-Tang Ho, Kuan-Hung Lu, Shih-Hang Lin, Suraphan Panyod, Yung-Lin Chu, Lee-Yan Sheen. Ginger Essential Oil Ameliorates Hepatic Injury and Lipid Accumulation in High Fat Diet-Induced Nonalcoholic Fatty Liver Disease. Journal of Agricultural and Food Chemistry 2016; 64(10): 2062 doi: 10.1021/acs.jafc.5b06159
|
| 125 |
Sheila Cristina L. Sanches, Leandra Naira Z. Ramalho, Marlei Josiele Augusto, Deisy Mara da Silva, Fernando Silva Ramalho. Nonalcoholic Steatohepatitis: A Search for Factual Animal Models. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/574832
|
| 126 |
Yu Feng, Yan Chen, Binrui Yang, Qingping Lan, Tao Wang, Guozhen Cui, Zhitao Ren, I. Cheong Choi, George Pak-Heng Leung, Fenggen Yan, Dacan Chen, Hon Ho Yu, Simon Ming Yuen Lee. Hepatoprotective Effect of Jianpi Huoxue Formula on Nonalcoholic Fatty Liver Disease Induced by Methionine-Choline-Deficient Diet in Rat. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7465272
|
| 127 |
Thatiany de Souza Marinho, Adriana Kawasaki, Marcus Bryntesson, Vanessa Souza‐Mello, Sandra Barbosa‐da‐Silva, Marcia B. Aguila, Carlos A. Mandarim‐de‐Lacerda. Rosuvastatin limits the activation of hepatic stellate cells in diet‐induced obese mice. Hepatology Research 2017; 47(9): 928 doi: 10.1111/hepr.12821
|
| 128 |
Briana Spolding, Timothy Connor, Carrie Wittmer, Lelia L. F. Abreu, Antony Kaspi, Mark Ziemann, Gunveen Kaur, Adrian Cooper, Shona Morrison, Scott Lee, Andrew Sinclair, Yann Gibert, James L. Trevaskis, Jonathon D. Roth, Assam El-Osta, Richard Standish, Ken Walder, Jean-Marc A. Lobaccaro. Rapid Development of Non-Alcoholic Steatohepatitis in Psammomys obesus (Israeli Sand Rat). PLoS ONE 2014; 9(3): e92656 doi: 10.1371/journal.pone.0092656
|
| 129 |
Haw-Wen Chen, Chih-Ching Yen, Li-Li Kuo, Chia-Wen Lo, Chin-Shiu Huang, Chih-Chieh Chen, Chong-Kuei Lii. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells. Toxicology and Applied Pharmacology 2020; 393: 114941 doi: 10.1016/j.taap.2020.114941
|
| 130 |
Hua‐jun Li, Yuan‐song Wang, Ya‐nan Wang, Ai‐ru Liu, Xiu‐hai Su, Zi‐ang Ma, Li‐xin Wang, Zhong‐yong Zhang, Shu‐quan Lv, Jing Miao, Huan‐tian Cui. Mechanical study of alisol B 23‐acetate on methionine and choline deficient diet‐induced nonalcoholic steatohepatitis based on untargeted metabolomics. Biomedical Chromatography 2024; 38(1) doi: 10.1002/bmc.5763
|
| 131 |
Pierre-Etienne Merret, Lydie Sparfel, Catherine Lavau, Dominique Lagadic-Gossmann, Corinne Martin-Chouly. Extracellular vesicles as a potential source of biomarkers for endocrine disruptors in MASLD: A short review on the case of DEHP. Biochimie 2025; 228: 127 doi: 10.1016/j.biochi.2024.09.009
|
| 132 |
Qing-Shan Wang, Min Li, Xiao Li, Na-Wei Zhang, Hui-Yan Hu, Lu-Lu Zhang, Jing-Nan Ren, Gang Fan, Si-Yi Pan. Protective effect of orange essential oil on the formation of non-alcoholic fatty liver disease caused by high-fat diet. Food & Function 2022; 13(2): 933 doi: 10.1039/D1FO03793E
|
| 133 |
Sadaf Dabeer, Sheikh Raisuddin. Perinatal exposure to environmental endocrine disruptor bisphenol A aggravates the onset of non-alcoholic fatty liver disease (NAFLD) in weanling F1 offspring of obese rats. Environmental Science and Pollution Research 2023; 30(2): 3146 doi: 10.1007/s11356-022-22246-y
|
| 134 |
Qian Yu, Zhengyun Xia, Emily Liong, George Tipoe. Chronic aerobic exercise improves insulin sensitivity and modulates Nrf2 and NF‑κB/IκBα pathways in the skeletal muscle of rats fed with a high fat diet. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10787
|
| 135 |
Bregje Van De Wier, Ger H. Koek, Aalt Bast, Guido R. M. M. Haenen. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. Critical Reviews in Food Science and Nutrition 2017; 57(4): 834 doi: 10.1080/10408398.2014.952399
|
| 136 |
Marta Correia de Sousa, Etienne Delangre, Flavien Berthou, Sanae El Harane, Christine Maeder, Margot Fournier, Karl-Heinz Krause, Monika Gjorgjieva, Michelangelo Foti. Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids. JHEP Reports 2024; 6(9): 101126 doi: 10.1016/j.jhepr.2024.101126
|
| 137 |
Marta Z. Pacia, Krzysztof Czamara, Magdalena Zebala, Edyta Kus, Stefan Chlopicki, Agnieszka Kaczor. Rapid diagnostics of liver steatosis by Raman spectroscopyviafiber optic probe: a pilot study. The Analyst 2018; 143(19): 4723 doi: 10.1039/C8AN00289D
|
| 138 |
Sandra Pisonero‐Vaquero, Ángel Martínez‐Ferreras, María Victoria García‐Mediavilla, Susana Martínez‐Flórez, Anna Fernández, Marta Benet, José Luis Olcoz, Ramiro Jover, Javier González‐Gallego, Sonia Sánchez‐Campos. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet‐induced mouse model of nonalcoholic fatty liver disease. Molecular Nutrition & Food Research 2015; 59(5): 879 doi: 10.1002/mnfr.201400913
|
| 139 |
Kamila Kochan, Edyta Maslak, Christoph Krafft, Renata Kostogrys, Stefan Chlopicki, Malgorzata Baranska. Raman spectroscopy analysis of lipid droplets content, distribution and saturation level in Non‐Alcoholic Fatty Liver Disease in mice. Journal of Biophotonics 2015; 8(7): 597 doi: 10.1002/jbio.201400077
|
| 140 |
Ling Xu, Megumi Kanasaki, Jianhua He, Munehiro Kitada, Kenji Nagao, Hiroko Jinzu, Yasushi Noguchi, Hiroshi Maegawa, Keizo Kanasaki, Daisuke Koya. Ketogenic essential amino acids replacement diet ameliorated hepatosteatosis with altering autophagy-associated molecules. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013; 1832(10): 1605 doi: 10.1016/j.bbadis.2013.05.003
|
| 141 |
Yoichiro Asai, Tetsuya Yamada, Sohei Tsukita, Kei Takahashi, Masamitsu Maekawa, Midori Honma, Masanori Ikeda, Keigo Murakami, Yuichiro Munakata, Yuta Shirai, Shinjiro Kodama, Takashi Sugisawa, Yumiko Chiba, Yasuteru Kondo, Keizo Kaneko, Kenji Uno, Shojiro Sawada, Junta Imai, Yasuhiro Nakamura, Hiroaki Yamaguchi, Kozo Tanaka, Hironobu Sasano, Nariyasu Mano, Yoshiyuki Ueno, Tooru Shimosegawa, Hideki Katagiri. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones. Gastroenterology 2017; 152(6): 1521 doi: 10.1053/j.gastro.2017.01.001
|
| 142 |
Ayşe Çakır Gündoğdu, Fatih Kar, Cansu Özbayer. Investigation of the Gastroprotective Effect of Betaine-Homocysteine Homeostasis on Oxidative Stress, Inflammation and Apoptosis in Ethanol-Induced Ulcer Model. Journal of Investigative Surgery 2022; 35(11-12): 1806 doi: 10.1080/08941939.2022.2126566
|
| 143 |
Soha S. Zakaria, Safaa M. Hanafy. Unraveling the Beneficial Role of Resveratrol in Fructose-Induced Non-Alcoholic Steatohepatitis with a Focus on the AMPK/Nrf2 Signaling Axis. Medicina 2025; 61(1): 139 doi: 10.3390/medicina61010139
|
| 144 |
Erdenetsogt Dungubat, Hiroyuki Kusano, Ichiro Mori, Hirosuke Tawara, Mitsuko Sutoh, Naoki Ohkura, Masakatsu Takanashi, Masahiko Kuroda, Naoki Harada, Emiko Udo, Masakazu Souda, Bungo Furusato, Toshio Fukusato, Yoshihisa Takahashi, Nobuyuki Takahashi. Age-dependent sex difference of non-alcoholic fatty liver disease in TSOD and db/db mice. PLOS ONE 2022; 17(12): e0278580 doi: 10.1371/journal.pone.0278580
|
| 145 |
Erenius Toppo, S. Sylvester Darvin, S. Esakkimuthu, K. Buvanesvaragurunathan, T.P. Ajeesh Krishna, S. Antony Caesar, A. Stalin, K. Balakrishna, P. Pandikumar, S. Ignacimuthu, N.A. Al-Dhabi. Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models. Biomedicine & Pharmacotherapy 2018; 107: 979 doi: 10.1016/j.biopha.2018.08.019
|
| 146 |
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
|
| 147 |
Natalie Chaves Cayuela, Gabrielly Pascoa Negreti, Roberto Rasslan, Marcia Kiyomi Koike, Edna Frasson de Souza Montero. Oxidative stress on ischemia/reperfusion injury in mice with non-alcoholic hepatic steatosis or steatohepatitis. Acta Cirurgica Brasileira 2018; 33(9): 753 doi: 10.1590/s0102-865020180090000003
|
| 148 |
Miyako Suzuki, Misato Kobayashi, Tamio Ohno, Shinsaku Kanamori, Soushi Tateishi, Atsushi Murai, Fumihiko Horio. Genetic dissection of the fatty liver QTL Fl1sa by using congenic mice and identification of candidate genes in the liver and epididymal fat. BMC Genetics 2016; 17(1) doi: 10.1186/s12863-016-0453-7
|
| 149 |
Mojtaba Daneshi, Pawel P. Borowicz, Mara R. Hirchert, Yssi L. Entzie, Jessica G. Syring, Layla E. King, Kazi Sarjana Safain, Muhammad Anas, Lawrence P. Reynolds, Alison K. Ward, Carl R. Dahlen, Matthew S. Crouse, Joel S. Caton. Influence of maternal nutrition and one-carbon metabolites supplementation on bovine antimicrobial peptides in fetal and maternal tissues. Frontiers in Veterinary Science 2024; 11 doi: 10.3389/fvets.2024.1505427
|
| 150 |
Katarzyna Majzner, Kamila Kochan, Neli Kachamakova-Trojanowska, Edyta Maslak, Stefan Chlopicki, Malgorzata Baranska. Raman Imaging Providing Insights into Chemical Composition of Lipid Droplets of Different Size and Origin: In Hepatocytes and Endothelium. Analytical Chemistry 2014; 86(13): 6666 doi: 10.1021/ac501395g
|
| 151 |
Koichi Tsuneyama. Animal models with minimal intervention for the translational study of metabolic syndrome-associated liver diseases. Kanzo 2018; 59(2): 92 doi: 10.2957/kanzo.59.92
|
| 152 |
Zoe Hall, Yajing Chu, Julian L. Griffin. Liquid Extraction Surface Analysis Mass Spectrometry Method for Identifying the Presence and Severity of Nonalcoholic Fatty Liver Disease. Analytical Chemistry 2017; 89(9): 5161 doi: 10.1021/acs.analchem.7b01097
|
| 153 |
Linqiang Zhang, Zhiguo Zhang, Yunhai Li, Shasha Liao, Xiaoyun Wu, Qing Chang, Bin Liang. Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease. Scientific Reports 2015; 5(1) doi: 10.1038/srep15970
|
| 154 |
Lindsei K. Sarna, Yaw L. Siow, Karmin O. The CBS/CSE system: a potential therapeutic target in NAFLD?. Canadian Journal of Physiology and Pharmacology 2015; 93(1): 1 doi: 10.1139/cjpp-2014-0394
|
| 155 |
Prasanna K. Santhekadur, Divya P. Kumar, Arun J. Sanyal. Preclinical models of non-alcoholic fatty liver disease. Journal of Hepatology 2018; 68(2): 230 doi: 10.1016/j.jhep.2017.10.031
|
| 156 |
Jorge A. Santos-López, Alba Garcimartín, Pinar Merino, M. Elvira López-Oliva, Sara Bastida, Juana Benedí, Francisco J. Sánchez-Muniz, Manuel Portero-Otin. Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets. PLOS ONE 2016; 11(1): e0147469 doi: 10.1371/journal.pone.0147469
|
| 157 |
Julia Schewe, Marie-Christine Makeschin, Andrej Khandoga, Jiang Zhang, Doris Mayr, Simon Rothenfußer, Max Schnurr, Alexander L. Gerbes, Christian J. Steib. To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning. Digestive Diseases and Sciences 2021; 66(4): 1349 doi: 10.1007/s10620-020-06328-w
|
| 158 |
Matthew D. Davidson, Joshua Pickrell, Salman R. Khetani. Physiologically inspired culture medium prolongs the lifetime and insulin sensitivity of human hepatocytes in micropatterned co-cultures. Toxicology 2021; 449: 152662 doi: 10.1016/j.tox.2020.152662
|
| 159 |
Zeinab El Rashed, Elena Grasselli, Hala Khalifeh, Laura Canesi, Ilaria Demori. Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease. Planta Medica 2022; 88(01): 9 doi: 10.1055/a-1273-3159
|
| 160 |
Yi-Syuan Lai, Wei-Cheng Chen, Tien-Chueh Kuo, Chi-Tang Ho, Ching-Hua Kuo, Yufeng J. Tseng, Kuan-Hung Lu, Shih-Hang Lin, Suraphan Panyod, Lee-Yan Sheen. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development. Journal of Agricultural and Food Chemistry 2015; 63(35): 7873 doi: 10.1021/acs.jafc.5b02830
|
| 161 |
Ravirajsinh Jadeja, Ranjitsinh V. Devkar, Srinivas Nammi, Menaka C. Thounaojam. Herbal Medicines for the Treatment of Nonalcoholic Steatohepatitis: Current Scenario and Future Prospects. Evidence-Based Complementary and Alternative Medicine 2014; 2014(1) doi: 10.1155/2014/648308
|
| 162 |
Franck Chiappini, Christophe Desterke, Justine Bertrand-Michel, Catherine Guettier, François Le Naour. Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models. Scientific Reports 2016; 6(1) doi: 10.1038/srep31587
|
| 163 |
Hui Li, John D. Clarke, Anika L. Dzierlenga, John Bear, Michael J. Goedken, Nathan J. Cherrington. In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice. Journal of Biochemical and Molecular Toxicology 2017; 31(2) doi: 10.1002/jbt.21840
|
| 164 |
Milena Vesković, Milica Labudović-Borović, Dušan Mladenović, Jelena Jadžić, Bojan Jorgačević, Dušan Vukićević, Danijela Vučević, Tatjana Radosavljević. Effect of Betaine Supplementation on Liver Tissue and Ultrastructural Changes in Methionine–Choline-Deficient Diet-Induced NAFLD. Microscopy and Microanalysis 2020; 26(5): 997 doi: 10.1017/S1431927620024265
|
| 165 |
Felix F. Lillich, John D. Imig, Ewgenij Proschak. Multi-Target Approaches in Metabolic Syndrome. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.554961
|
| 166 |
Dany Patoine, Xavier Levac, Sylvie Pilote, Benoit Drolet, Chantale Simard. Decreased CYP3A Expression and Activity in Guinea Pig Models of Diet-Induced Metabolic Syndrome: Is Fatty Liver Infiltration Involved?. Drug Metabolism and Disposition 2013; 41(5): 952 doi: 10.1124/dmd.112.050641
|
| 167 |
Boushra Bathish, Holly Robertson, John F. Dillon, Albena T. Dinkova-Kostova, John D. Hayes. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2. Free Radical Biology and Medicine 2022; 188: 221 doi: 10.1016/j.freeradbiomed.2022.06.226
|
| 168 |
Brett M. McGettigan, Rachel H. McMahan, Yuhuan Luo, Xiaoxin X. Wang, David J. Orlicky, Cara Porsche, Moshe Levi, Hugo R. Rosen. Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease. Journal of Biological Chemistry 2016; 291(44): 23058 doi: 10.1074/jbc.M116.731042
|
| 169 |
Isabel Freitas, Eleonora Boncompagni, Eleonora Tarantola, Cristian Gruppi, Vittorio Bertone, Andrea Ferrigno, Gloria Milanesi, Rita Vaccarone, M. Enrica Tira, Mariapia Vairetti, Francisco Javier Romero. In Situ Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine‐ and Choline‐Deficient Diet. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/9307064
|
| 170 |
Masayuki Sudoh, Masahiko Matsumoto. An approach for anti-fibrotic drug discovery in NASH. Folia Pharmacologica Japonica 2014; 144(2): 69 doi: 10.1254/fpj.144.69
|
| 171 |
Ayaka Iida, Sachi Kuranuki, Ryoko Yamamoto, Masaya Uchida, Masanori Ohta, Mayuko Ichimura, Koichi Tsuneyama, Takayuki Masaki, Masataka Seike, Tsuyoshi Nakamura. Analysis of amino acid profiles of blood over time and biomarkers associated with non-alcoholic steatohepatitis in STAM mice. Experimental Animals 2019; 68(4): 417 doi: 10.1538/expanim.18-0152
|
| 172 |
William P. Esler, David E. Cohen. Pharmacologic inhibition of lipogenesis for the treatment of NAFLD. Journal of Hepatology 2024; 80(2): 362 doi: 10.1016/j.jhep.2023.10.042
|
| 173 |
Korry J Hintze, Abby D Benninghoff, Clara E Cho, Robert E Ward. Modeling the Western Diet for Preclinical Investigations. Advances in Nutrition 2018; 9(3): 263 doi: 10.1093/advances/nmy002
|
| 174 |
Neti Jayanti, Rozzana Said, Suhaidah Jofrry, Chee-Yan Choo. Mechanistic pathway of herbs in the amelioration of NAFLD: A systematic review. World Academy of Sciences Journal 2024; 6(4) doi: 10.3892/wasj.2024.245
|
| 175 |
Yulia A. Nevzorova, Zoe Boyer-Diaz, Francisco Javier Cubero, Jordi Gracia-Sancho. Animal models for liver disease – A practical approach for translational research. Journal of Hepatology 2020; 73(2): 423 doi: 10.1016/j.jhep.2020.04.011
|
| 176 |
Mikheil Gogiashvili, Karolina Edlund, Kathrin Gianmoena, Rosemarie Marchan, Alexander Brik, Jan T. Andersson, Jörg Lambert, Katrin Madjar, Birte Hellwig, Jörg Rahnenführer, Jan G. Hengstler, Roland Hergenröder, Cristina Cadenas. Metabolic profiling of ob/ob mouse fatty liver using HR-MAS 1H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway. Analytical and Bioanalytical Chemistry 2017; 409(6): 1591 doi: 10.1007/s00216-016-0100-1
|
| 177 |
Jun Peng, Yi Huan, Qian Jiang, Su-juan Sun, Chun-ming Jia, Zhu-fang Shen. Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice. PPAR Research 2014; 2014: 1 doi: 10.1155/2014/538183
|
| 178 |
Lu Li, Jingqi Fu, Jing Sun, Dan Liu, Chengjie Chen, Huihui Wang, Yongyong Hou, Yuanyuan Xu, Jingbo Pi. Is Nrf2-ARE a potential target in NAFLD mitigation?. Current Opinion in Toxicology 2019; 13: 35 doi: 10.1016/j.cotox.2018.12.005
|
| 179 |
Edgar Vinicio Villalpando-Arteaga, Edgar Mendieta-Condado, Hugo Esquivel-Solís, Arturo Alejandro Canales-Aguirre, Francisco Javier Gálvez-Gastélum, Juan Carlos Mateos-Díaz, Jorge Alberto Rodríguez-González, Ana Laura Márquez-Aguirre. Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-γ and SREBP-1c in diet-induced obese mice. Food & Function 2013; 4(4): 618 doi: 10.1039/c3fo30270a
|
| 180 |
Adeline Bertola. WITHDRAWN: Rodent models of fatty liver diseases. Liver Research 2018; doi: 10.1016/j.livres.2018.02.005
|
| 181 |
Franck Chiappini, Audrey Coilly, Hanane Kadar, Philippe Gual, Albert Tran, Christophe Desterke, Didier Samuel, Jean-Charles Duclos-Vallée, David Touboul, Justine Bertrand-Michel, Alain Brunelle, Catherine Guettier, François Le Naour. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients. Scientific Reports 2017; 7(1) doi: 10.1038/srep46658
|
| 182 |
Juan Du, Xuemei Cao, Junlin Diao, Qijuan Zhang, Chuan Peng, Jibin Li, Xiaoqiu Xiao. Neonatal overfeeding in mice aggravates the development of methionine and choline-deficient diet-induced steatohepatitis in adulthood. Genes & Diseases 2019; 6(1): 68 doi: 10.1016/j.gendis.2017.12.008
|
| 183 |
Christoph Eilenberger, Florian Selinger, Mario Rothbauer, Yiji Lin, Andreas Limbeck, Barbara Schädl, Johannes Grillari, Nataliya S. Kavok, Vladimir K. Klochkov, Yuri V. Malyukin, Victor Margitich, Peter Ertl. Cytotoxicity, Retention, and Anti-inflammatory Effects of a CeO2 Nanoparticle-Based Supramolecular Complex in a 3D Liver Cell Culture Model. ACS Pharmacology & Translational Science 2021; 4(1): 101 doi: 10.1021/acsptsci.0c00170
|
| 184 |
Saravanan T., Shanmugapriya S., Eliz Thomas, Karthika P.. A Study to Evaluate the Efficacy of Saroglitazar in Non-Alcoholic Steatohepatitis Induced by High Fructose Diet Rat Model. Journal of Pharmacology and Pharmacotherapeutics 2023; 14(3): 201 doi: 10.1177/0976500X231213486
|
| 185 |
Naohiko Nakamura, Etsuro Hatano, Kohta Iguchi, Motohiko Sato, Hiroaki Kawaguchi, Iwao Ohtsu, Takaki Sakurai, Nobuhiro Aizawa, Hiroko Iijima, Shuhei Nishiguchi, Takuya Tomono, Yukihiro Okuda, Seidai Wada, Satoru Seo, Kojiro Taura, Shinji Uemoto, Masaya Ikegawa. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5825-8
|
| 186 |
Jacques Delarue, Jean‐Paul Lallès. Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long‐chain n‐3 PUFA. Molecular Nutrition & Food Research 2016; 60(1): 147 doi: 10.1002/mnfr.201500346
|
| 187 |
Ji-Young Choi, Ye Kim, Su-Jung Cho, Eun-Young Kwon, Ri Ryu, Myung-Sook Choi. Metabolic Effect of an Oriental Herbal Medicine on Obesity and Its Comorbidities with Transcriptional Responses in Diet-Induced Obese Mice. International Journal of Molecular Sciences 2017; 18(4): 747 doi: 10.3390/ijms18040747
|
| 188 |
Kyu-Ho Song, Min-Young Lee, Chi-Hyeon Yoo, Song-I Lim, Bo-Young Choe. Improved quantitative fatty acid values with correction of T2 relaxation time in terminal methyl group: In vivo proton magnetic resonance spectroscopy at ultra high field in hepatic steatosis. Chemistry and Physics of Lipids 2018; 212: 35 doi: 10.1016/j.chemphyslip.2018.01.004
|
| 189 |
Bernardete F. Melo, Joana F. Sacramento, Maria J. Ribeiro, Claudia S. Prego, Miguel C. Correia, Joana C. Coelho, Joao P. Cunha-Guimaraes, Tiago Rodrigues, Ines B. Martins, Maria P. Guarino, Raquel M. Seiça, Paulo Matafome, Silvia V. Conde. Evaluating the Impact of Different Hypercaloric Diets on Weight Gain, Insulin Resistance, Glucose Intolerance, and its Comorbidities in Rats. Nutrients 2019; 11(6): 1197 doi: 10.3390/nu11061197
|
| 190 |
Hongyan Qi, Shanshan Jiang, Jiang Nan, Hang Guo, Cai Cheng, Xin He, Hongyang Jin, Rongfan Zhang, Junqiang Lei. Application and research progress of magnetic resonance proton density fat fraction in metabolic dysfunction-associated steatotic liver disease: a comprehensive review. Abdominal Radiology 2024; 50(1): 185 doi: 10.1007/s00261-024-04448-9
|
| 191 |
Dalia O. Saleh, Rania F. Ahmed, Mohamed M. Amin. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats. Applied Physiology, Nutrition, and Metabolism 2017; 42(3): 243 doi: 10.1139/apnm-2016-0320
|
| 192 |
Li Zhong, Lu Huang, Qian Xue, Chang Liu, Keshu Xu, Wei Shen, Liang Deng. Cell‐specific elevation of Runx2 promotes hepatic infiltration of macrophages by upregulating MCP‐1 in high‐fat diet‐induced mice NAFLD. Journal of Cellular Biochemistry 2019; 120(7): 11761 doi: 10.1002/jcb.28456
|
| 193 |
Dimitrios G Bouzianas, Stella D Bouziana, Apostolos I Hatzitolios. Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids. Nutrition Reviews 2013; 71(11): 753 doi: 10.1111/nure.12073
|
| 194 |
Hadi Emamat, Maryam Noori, Forough Foroughi, Marjan Rismanchi, Hassan Eini–Zinab, Azita Hekmatdoost. An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease. Middle East Journal of Digestive Diseases 2016; 8(2): 109 doi: 10.15171/mejdd.2016.15
|
| 195 |
Alini Schultz, Debora Neil, Marcia Aguila, Carlos Mandarim-de-Lacerda. Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/Obesity. International Journal of Molecular Sciences 2013; 14(11): 21873 doi: 10.3390/ijms141121873
|
| 196 |
Yiming Zhang, Zexi Zhang, Miaomiao Wu, Run Zhang. Advances and Perspectives of Responsive Probes for Measuring γ-Glutamyl Transpeptidase. ACS Measurement Science Au 2024; 4(1): 54 doi: 10.1021/acsmeasuresciau.3c00045
|
| 197 |
Daisuke Yasuda, Haruki Torii, Rumiko Shimizu, Yoshinori Hiraoka, Noriaki Kume. Reduced Serum Cholesterol and Triglyceride Levels in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet (CDAHFD)-Induced Mouse Model of Non-alcoholic Steatohepatitis (NASH). Biological and Pharmaceutical Bulletin 2020; 43(4): 616 doi: 10.1248/bpb.b19-00338
|
| 198 |
Peter Lykke Eriksen, Karen Louise Thomsen, Stephen Hamilton-Dutoit, Hendrik Vilstrup, Michael Sørensen. Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02574-6
|
| 199 |
Hirofumi Okubo, Akifumi Kushiyama, Hideyuki Sakoda, Yusuke Nakatsu, Masaki Iizuka, Naoyuki Taki, Midori Fujishiro, Toshiaki Fukushima, Hideaki Kamata, Akiko Nagamachi, Toshiya Inaba, Fusanori Nishimura, Hideki Katagiri, Takashi Asahara, Yasuto Yoshida, Osamu Chonan, Jeffery Encinas, Tomoichiro Asano. Involvement of resistin-like molecule β in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice. Scientific Reports 2016; 6(1) doi: 10.1038/srep20157
|
| 200 |
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Basic Protocols in Foods and Nutrition. Methods and Protocols in Food Science 2022; : 53 doi: 10.1007/978-1-0716-2345-9_4
|
| 201 |
Ngoc Anh Hoang, Friederike Richter, Martin Schubert, Stefan Lorkowski, Lars-Oliver Klotz, Holger Steinbrenner. Differential capability of metabolic substrates to promote hepatocellular lipid accumulation. European Journal of Nutrition 2019; 58(8): 3023 doi: 10.1007/s00394-018-1847-2
|
| 202 |
Dandan Liang, Hongjin Chen, Leping Zhao, Wenxin Zhang, Jie Hu, Zhiguo Liu, Peng Zhong, Wei Wang, Jingying Wang, Guang Liang. Inhibition of EGFR attenuates fibrosis and stellate cell activation in diet-induced model of nonalcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(1): 133 doi: 10.1016/j.bbadis.2017.10.016
|
| 203 |
Mikael Bjursell, Marianne Wedin, Therése Admyre, Majlis Hermansson, Gerhard Böttcher, Melker Göransson, Daniel Lindén, Krister Bamberg, Jan Oscarsson, Mohammad Bohlooly-Y, Carlos M. Rodriguez-Ortigosa. Ageing Fxr Deficient Mice Develop Increased Energy Expenditure, Improved Glucose Control and Liver Damage Resembling NASH. PLoS ONE 2013; 8(5): e64721 doi: 10.1371/journal.pone.0064721
|
| 204 |
Asrın NALBANT, Bayram Ufuk ŞAKUL, Ferruh YÜCEL. Investigation of Changes in Liver Microanatomy in the Steatosis Model Created by Permanent Canula in Rats. Clinical and Experimental Health Sciences 2022; 12(3): 659 doi: 10.33808/clinexphealthsci.948391
|
| 205 |
Evelyn Albu, Heather Lasseter. Would You Figure It Out? Differential Diagnoses: Beyond the Usual. EMJ Hepatology 2015; : 60 doi: 10.33590/emjhepatol/10312324
|
| 206 |
A.K. Kopec, N. Joshi, J.P. Luyendyk. Role of hemostatic factors in hepatic injury and disease: animal models de‐liver. Journal of Thrombosis and Haemostasis 2016; 14(7): 1337 doi: 10.1111/jth.13327
|
| 207 |
Peng Gao, Cheng Chang, Jieling Liang, Fen Du, Ruilin Zhang. Embryonic Amoxicillin Exposure Has Limited Impact on Liver Development but Increases Susceptibility to NAFLD in Zebrafish Larvae. International Journal of Molecular Sciences 2024; 25(5): 2744 doi: 10.3390/ijms25052744
|
| 208 |
Mark J. Canet, Rhiannon N. Hardwick, April D. Lake, Anika L. Dzierlenga, John D. Clarke, Nathan J. Cherrington. Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models. Drug Metabolism and Disposition 2014; 42(4): 586 doi: 10.1124/dmd.113.055996
|
| 209 |
Enas Ahmed Abd El-Haleim. Molecular Study on the Potential Protective Effects of Bee Venom against Fructose-Induced Nonalcoholic Steatohepatitis in Rats. Pharmacology 2020; 105(11-12): 692 doi: 10.1159/000508511
|
| 210 |
Xiao-Hong Liu, Xu Pang, Li Jin, De-Yong Pu, Zhi-Jian Wang, Yao-Guang Zhang. Exposure to acute waterborne cadmium caused severe damage on lipid metabolism of freshwater fish, revealed by nuclear lipid droplet deposition in hepatocytes of rare minnow. Aquatic Toxicology 2023; 257: 106433 doi: 10.1016/j.aquatox.2023.106433
|
| 211 |
Byunghun So, Li Li Ji, Saba Imdad, Chounghun Kang, Marcia B. Aguila. Proteomic analysis of the effect of high-fat-diet and voluntary physical activity on mouse liver. PLOS ONE 2022; 17(8): e0273049 doi: 10.1371/journal.pone.0273049
|
| 212 |
Tovit Rosenzweig, Nir Skalka, Konstantin Rozenberg, Uriel Elyasiyan, Anna Pinkus, Benzi Green, Maria Stanevsky, Elyashiv Drori. Red wine and wine pomace reduced the development of insulin resistance and liver steatosis in HFD-fed mice. Journal of Functional Foods 2017; 34: 379 doi: 10.1016/j.jff.2017.04.043
|
| 213 |
Victoria Sid, Nan Wu, Lindsei K. Sarna, Yaw L. Siow, James D. House, Karmin O. Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2015; 309(10): R1215 doi: 10.1152/ajpregu.00260.2015
|
| 214 |
Larisse Longo, Jéssica Tonin Ferrari, Pabulo Henrique Rampelotto, Gustavo Hirata Dellavia, Amanda Pasqualotto, Claudia P Oliveira, Carlos Thadeu Schmidt Cerski, Themis Reverbel da Silveira, Carolina Uribe-Cruz, Mário Reis Álvares-da-Silva. <p>Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats</p>. Clinical and Experimental Gastroenterology 2020; : 351 doi: 10.2147/CEG.S262879
|
| 215 |
Mengyao Zhao, Liming Zhao. Oligosaccharides of Chitin and Chitosan. 2019; : 163 doi: 10.1007/978-981-13-9402-7_8
|
| 216 |
Sou Hyun Kim, Yong Lim, Ju Bin Park, Jae-Hwan Kwak, Keuk-Jun Kim, Joung-Hee Kim, HyunKeun Song, Joon Young Cho, Dae Youn Hwang, Kil Soo Kim, Young-Suk Jung. Comparative study of fatty liver induced by methionine and choline-deficiency in C57BL/6N mice originating from three different sources. Laboratory Animal Research 2017; 33(2): 157 doi: 10.5625/lar.2017.33.2.157
|
| 217 |
Yu. G. Pritulina, S. E. Prokopenko, A. A. Kordenko, D. A. Atyakshin, V. L. Lobanov. Evaluation of the effect of remaxol on hepatocytes in non-alcoholic fatty liver dystrophy modeling in laboratory C57BL/6 mice. Arkhiv patologii 2019; 81(5): 64 doi: 10.17116/patol20198105164
|
| 218 |
May G. Akl, Scott B. Widenmaier. Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2023; 10 doi: 10.3389/fcell.2022.1089124
|
| 219 |
Adeline Bertola. Rodent models of fatty liver diseases. Liver Research 2018; 2(1): 3 doi: 10.1016/j.livres.2018.03.001
|
| 220 |
Milena N. Stanković, Dušan R. Mladenović, Ivana Đuričić, Slađana S. Šobajić, Jasmina Timić, Bojan Jorgačević, Vuk Aleksić, Danijela B. Vučević, Rada Ješić-Vukićević, Tatjana S. Radosavljević. Time-dependent Changes and Association Between Liver Free Fatty Acids, Serum Lipid Profile and Histological Features in Mice Model of Nonalcoholic Fatty Liver Disease. Archives of Medical Research 2014; 45(2): 116 doi: 10.1016/j.arcmed.2013.12.010
|
| 221 |
Simonetta Caira, Antonio Iannelli, Rosaria Sciarrillo, Gianluca Picariello, Giovanni Renzone, Andrea Scaloni, Pietro Addeo. Differential representation of liver proteins in obese human subjects suggests novel biomarkers and promising targets for drug development in obesity. Journal of Enzyme Inhibition and Medicinal Chemistry 2017; 32(1): 672 doi: 10.1080/14756366.2017.1292262
|
| 222 |
Tomas Jelenik, Kirti Kaul, Gilles Séquaris, Ulrich Flögel, Esther Phielix, Jörg Kotzka, Birgit Knebel, Pia Fahlbusch, Tina Hörbelt, Stefan Lehr, Anna Lena Reinbeck, Dirk Müller-Wieland, Irene Esposito, Gerald I. Shulman, Julia Szendroedi, Michael Roden. Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver. Diabetes 2017; 66(8): 2241 doi: 10.2337/db16-1147
|
| 223 |
Michael J. Duryee, Monte S. Willis, Courtney S. Schaffert, Roger D. Reidelberger, Anand Dusad, Daniel R. Anderson, Lynell W. Klassen, Geoffrey M. Thiele. Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 306(3): G208 doi: 10.1152/ajpgi.00124.2013
|
| 224 |
Zachary J. Brown, Bernd Heinrich, Tim F. Greten. Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research. Nature Reviews Gastroenterology & Hepatology 2018; 15(9): 536 doi: 10.1038/s41575-018-0033-6
|
| 225 |
Maria Luíza R. P. Lima, Laura H. R. Leite, Carolina R. Gioda, Fabíola O. P. Leme, Claudia A. Couto, Cândido C. Coimbra, Virginia H. R. Leite, Teresa Cristina A. Ferrari. A Novel Wistar Rat Model of Obesity-Related Nonalcoholic Fatty Liver Disease Induced by Sucrose-Rich Diet. Journal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/9127076
|
| 226 |
Yoshihisa Takahashi, Yurie Soejima, Arisa Kumagai, Masato Watanabe, Hiroshi Uozaki, Toshio Fukusato. Japanese herbal medicines shosaikoto, inchinkoto, and juzentaihoto inhibit high‐fat diet‐induced nonalcoholic steatohepatitis in db/db mice. Pathology International 2014; 64(10): 490 doi: 10.1111/pin.12199
|
| 227 |
Seon-Ok Lee, Yinzhu Xu, Hengmin Han, Seok-Tae Jeong, You-Kyung Lee, Jean Kyung Paik, Jin-Sol Cha, Hyo-Jeong Lee. Fermented Rhus Verniciflua Stokes Extract Alleviates Nonalcoholic Fatty Liver through the AMPK/SREBP1/PCSK9 Pathway in HFD-Induced Nonalcoholic Fatty Liver Animal Model. Applied Sciences 2020; 10(19): 6833 doi: 10.3390/app10196833
|
| 228 |
Jacqueline Ruiz‐Canizales, J. Abraham Domínguez‐Avila, Abraham Wall‐Medrano, J. Fernando Ayala‐Zavala, Aarón F. González‐Córdova, Belinda Vallejo‐Córdoba, Norma Julieta Salazar‐López, Gustavo A. González‐Aguilar. Fiber and phenolic compounds contribution to the hepatoprotective effects of mango diets in rats fed high cholesterol/sodium cholate. Phytotherapy Research 2019; 33(11): 2996 doi: 10.1002/ptr.6479
|
| 229 |
Yi-Syuan Lai, Wei-Cheng Chen, Chi-Tang Ho, Kuan-Hung Lu, Shih-Hang Lin, Hui-Chun Tseng, Shuw-Yuan Lin, Lee-Yan Sheen. Garlic Essential Oil Protects against Obesity-Triggered Nonalcoholic Fatty Liver Disease through Modulation of Lipid Metabolism and Oxidative Stress. Journal of Agricultural and Food Chemistry 2014; 62(25): 5897 doi: 10.1021/jf500803c
|
| 230 |
Alexandria M. Szalanczy, Chrissy Sherrill, Katherine M. Fanning, Barry Hart, David Caudell, Ashley W. Davis, Jordyn Whitfield, Kylie Kavanagh. A Novel TGFβ Receptor Inhibitor, IPW-5371, Prevents Diet-induced Hepatic Steatosis and Insulin Resistance in Irradiated Mice. Radiation Research 2024; 202(1) doi: 10.1667/RADE-23-00202.1
|
| 231 |
Philippe Lefebvre, Fanny Lalloyer, Eric Baugé, Michal Pawlak, Céline Gheeraert, Hélène Dehondt, Jonathan Vanhoutte, Eloise Woitrain, Nathalie Hennuyer, Claire Mazuy, Marie Bobowski-Gérard, Francesco Paolo Zummo, Bruno Derudas, Ann Driessen, Guy Hubens, Luisa Vonghia, Wilhelmus J. Kwanten, Peter Michielsen, Thomas Vanwolleghem, Jérôme Eeckhoute, An Verrijken, Luc Van Gaal, Sven Francque, Bart Staels. Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin. JCI Insight 2017; 2(13) doi: 10.1172/jci.insight.92264
|
| 232 |
Jose Cordoba-Chacon. Loss of Hepatocyte-Specific PPARγ Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet. PPAR Research 2020; 2020: 1 doi: 10.1155/2020/9735083
|
| 233 |
Shanhong Lu, Ting Zhang, Wen Gu, Xingxin Yang, Jianmei Lu, Ronghua Zhao, Jie Yu. Volatile Oil ofAmomum villosumInhibits Nonalcoholic Fatty Liver Disease via the Gut-Liver Axis. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3589874
|
| 234 |
P. León-Mimila, H. Villamil-Ramírez, X.S. Li, D.M. Shih, S.T. Hui, E. Ocampo-Medina, B. López-Contreras, S. Morán-Ramos, M. Olivares-Arevalo, P. Grandini-Rosales, L. Macías-Kauffer, I. González-González, R. Hernández-Pando, F. Gómez-Pérez, F. Campos-Pérez, C. Aguilar-Salinas, E. Larrieta-Carrasco, T. Villarreal-Molina, Z. Wang, A.J. Lusis, S.L. Hazen, A. Huertas-Vazquez, S. Canizales-Quinteros. Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes. Diabetes & Metabolism 2021; 47(2): 101183 doi: 10.1016/j.diabet.2020.07.010
|
| 235 |
Robert Schierwagen, Lara Maybüchen, Sebastian Zimmer, Kanishka Hittatiya, Christer Bäck, Sabine Klein, Frank E. Uschner, Winfried Reul, Peter Boor, Georg Nickenig, Christian P. Strassburg, Christian Trautwein, Jogchum Plat, Dieter Lütjohann, Tilman Sauerbruch, Frank Tacke, Jonel Trebicka. Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis. Scientific Reports 2015; 5(1) doi: 10.1038/srep12931
|
| 236 |
Cong Zhang, Yuzhen Lu, Yingying Song, Liang Chen, Junjie Hu, Yan Meng, Xin Chen, Shan Li, Guohua Zheng, Zhenpeng Qiu. Celecoxib attenuates hepatosteatosis by impairing de novo lipogenesis via Akt‐dependent lipogenic pathway. Journal of Cellular and Molecular Medicine 2022; 26(14): 3995 doi: 10.1111/jcmm.17435
|
| 237 |
Yohei Saito, Yoshikazu Kuwahara, Yumi Yamamoto, Masatoshi Suzuki, Manabu Fukumoto, Fumihiko Yamamoto. ddY Mice Fed 10% Fat Diet Exhibit High p27KIP Expression and Delayed Hepatocyte DNA Synthesis During Liver Regeneration. Metabolic Syndrome and Related Disorders 2018; 16(6): 305 doi: 10.1089/met.2017.0131
|
| 238 |
Melanie Penke, Per S. Larsen, Susanne Schuster, Morten Dall, Benjamin A.H. Jensen, Theresa Gorski, Andrej Meusel, Sandy Richter, Sara G. Vienberg, Jonas T. Treebak, Wieland Kiess, Antje Garten. Hepatic NAD salvage pathway is enhanced in mice on a high-fat diet. Molecular and Cellular Endocrinology 2015; 412: 65 doi: 10.1016/j.mce.2015.05.028
|
| 239 |
Jennie Ka Ching Lau, Xiang Zhang, Jun Yu. Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances. The Journal of Pathology 2017; 241(1): 36 doi: 10.1002/path.4829
|
| 240 |
Ying-Rong LENG, Mei-Hui ZHANG, Jian-Guang LUO, Hao ZHANG. Pathogenesis of NASH and Promising Natural Products. Chinese Journal of Natural Medicines 2021; 19(1): 12 doi: 10.1016/S1875-5364(21)60002-X
|
| 241 |
Hieu Huy Phung, Chang Hoon Lee. Mouse models of nonalcoholic steatohepatitis and their application to new drug development. Archives of Pharmacal Research 2022; 45(11): 761 doi: 10.1007/s12272-022-01410-5
|
| 242 |
Jiang Zhang, Julia Schewe, Hanwei Li, Marie-Christine Makeschin, Ujjwal M. Mahajan, Alexander L. Gerbes, Christian J. Steib. The effects of hepatic steatosis on thromboxane A2 induced portal hypertension. Gastroenterología y Hepatología (English Edition) 2019; 42(9): 534 doi: 10.1016/j.gastre.2019.03.021
|
| 243 |
Wenlong Nie, Yang Yang, Ling Li, Yue Ding, Xingmi Chen, Ming Li, Ning He, Guang Ji, Yong Zhang, Ping Kang, Tong Zhang. Comparison of pharmacokinetic profiles of seven major bioactive components in normal and non-alcoholic fatty liver disease (NAFLD) rats after oral administration of Ling-Gui-Zhu-Gan decoction by UPLC-MS/MS. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1174742
|
| 244 |
Yaqing Wang, Hui Wang, Pengwei Deng, Tingting Tao, Haitao Liu, Shuo Wu, Wenwen Chen, Jianhua Qin. Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System. ACS Biomaterials Science & Engineering 2020; 6(10): 5734 doi: 10.1021/acsbiomaterials.0c00682
|
| 245 |
Marta Benet, Carla Guzmán, Sandra Pisonero-Vaquero, M. Victoria García-Mediavilla, Sonia Sánchez-Campos, M. Luz Martínez-Chantar, M. Teresa Donato, José Vicente Castell, Ramiro Jover. Repression of the Nuclear Receptor Small Heterodimer Partner by Steatotic Drugs and in Advanced Nonalcoholic Fatty Liver Disease. Molecular Pharmacology 2015; 87(4): 582 doi: 10.1124/mol.114.096313
|
| 246 |
Sonal Josan, Kelvin Billingsley, Juan Orduna, Jae Mo Park, Richard Luong, Liqing Yu, Ralph Hurd, Adolf Pfefferbaum, Daniel Spielman, Dirk Mayer. Assessing inflammatory liver injury in an acute CCl4model using dynamic 3D metabolic imaging of hyperpolarized [1-13C]pyruvate. NMR in Biomedicine 2015; 28(12): 1671 doi: 10.1002/nbm.3431
|
| 247 |
Jason R. Clapper, Michelle D. Hendricks, Guibao Gu, Carrie Wittmer, Carrie S. Dolman, John Herich, Jennifer Athanacio, Christiane Villescaz, Soumitra S. Ghosh, Joseph S. Heilig, Carolyn Lowe, Jonathan D. Roth. Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 305(7): G483 doi: 10.1152/ajpgi.00079.2013
|
| 248 |
Yoshitaka Kondo, Akihito Ishigami. Involvement of senescence marker protein‐30 in glucose metabolism disorder and non‐alcoholic fatty liver disease. Geriatrics & Gerontology International 2016; 16(S1): 4 doi: 10.1111/ggi.12722
|
| 249 |
Éric Jubinville, Nadia Milad, Michaël Maranda-Robitaille, Marc-Alexandre Lafrance, Marie Pineault, Jennifer Lamothe, Joanie Routhier, Marie-Josée Beaulieu, Sophie Aubin, Mathieu Laplante, Mathieu C. Morissette. Critical importance of dietary methionine and choline in the maintenance of lung homeostasis during normal and cigarette smoke exposure conditions. American Journal of Physiology-Lung Cellular and Molecular Physiology 2020; 319(2): L391 doi: 10.1152/ajplung.00353.2019
|
| 250 |
Anna Kakehashi, Arpamas Chariyakornkul, Shugo Suzuki, Napaporn Khuanphram, Kumiko Tatsumi, Shotaro Yamano, Masaki Fujioka, Min Gi, Rawiwan Wongpoomchai, Hideki Wanibuchi. Cache Domain Containing 1 Is a Novel Marker of Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis. Cancers 2021; 13(6): 1216 doi: 10.3390/cancers13061216
|
| 251 |
Alessandro Federico, Valerio Rosato, Mario Masarone, Pietro Torre, Marcello Dallio, Mario Romeo, Marcello Persico. The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights. Nutrients 2021; 13(4): 1314 doi: 10.3390/nu13041314
|
| 252 |
Daniël A. Lionarons, Michal Heger, Rowan F. van Golen, Lindy K. Alles, Vincent A. van der Mark, Jaap J. Kloek, Dirk R. de Waart, Hendrik A. Marsman, Henny Rusch, Joanne Verheij, Ulrich Beuers, Coen C. Paulusma, Thomas M. van Gulik. Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport. Scientific Reports 2016; 6(1) doi: 10.1038/srep31829
|
| 253 |
Antonio Carlos Soares Pantaleão, Marcio Pinto de Castro, Krishynan Shanty Fernandes Meirelles Araujo, Carlos Frederico Ferreira Campos, André Luiz Alves da Silva, José Eduardo Ferreira Manso, João Carlos Machado. Ultrasound biomicroscopy for the assessment of early-stage nonalcoholic fatty liver disease induced in rats by a high-fat diet. Ultrasonography 2022; 41(4): 750 doi: 10.14366/usg.21182
|
| 254 |
Krzysztof Kurek, Dominika M. Piotrowska, Patrycja Wiesiołek‐Kurek, Bartłomiej Łukaszuk, Adrian Chabowski, Jan Górski, Małgorzata Żendzian‐Piotrowska. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. Liver International 2014; 34(7): 1074 doi: 10.1111/liv.12331
|
| 255 |
Michael A. Wells, Kimberly C. Vendrov, Matthew L. Edin, Brian C. Ferslew, Weibin Zha, Bobbie K.H. Nguyen, Rachel J. Church, Fred B. Lih, Laura M. DeGraff, Kim L.R. Brouwer, A. Sidney Barritt, Darryl C. Zeldin, Craig R. Lee. Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis. Prostaglandins & Other Lipid Mediators 2016; 125: 19 doi: 10.1016/j.prostaglandins.2016.07.002
|
| 256 |
Wenhui Yang, Yan He, Shijie Liu, Lulu Gan, Zhiguo Zhang, Jun Wang, Jie Liang, Yang Dong, Qing Wang, Zongliu Hou, Li Yang. Integrative transcriptomic analysis of NAFLD animal model reveals dysregulated genes and pathways in metabolism. Gene 2016; 595(1): 99 doi: 10.1016/j.gene.2016.09.047
|
| 257 |
Anna Kakehashi, Shugo Suzuki, Naomi Ishii, Takahiro Okuno, Yuko Kuwae, Masaki Fujioka, Min Gi, Vasily Stefanov, Hideki Wanibuchi. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis. International Journal of Molecular Sciences 2020; 21(20): 7746 doi: 10.3390/ijms21207746
|
| 258 |
Vanessa Souza-Mello. Nonalcoholic Steatohepatitis: Lessons from Different Diet-induced Animal Models. Journal of Diabetes, Metabolic Disorders & Control 2014; 1(3) doi: 10.15406/jdmdc.2014.01.00014
|
| 259 |
Ines C.M. Simoes, Justyna Janikiewicz, Judith Bauer, Agnieszka Karkucinska-Wieckowska, Piotr Kalinowski, Agnieszka Dobrzyń, Andrzej Wolski, Maciej Pronicki, Krzysztof Zieniewicz, Paweł Dobrzyń, Marcin Krawczyk, Hans Zischka, Mariusz R. Wieckowski, Yaiza Potes. Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(12): 2871 doi: 10.3390/nu11122871
|
| 260 |
Milena Veskovic, Dusan Mladenovic, Marina Milenkovic, Jelena Tosic, Suncica Borozan, Kristina Gopcevic, Milica Labudovic-Borovic, Vesna Dragutinovic, Danijela Vucevic, Bojan Jorgacevic, Aleksandra Isakovic, Vladimir Trajkovic, Tatjana Radosavljevic. Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease. European Journal of Pharmacology 2019; 848: 39 doi: 10.1016/j.ejphar.2019.01.043
|
| 261 |
Hyelin Na, Ho Lee, Min-Ho Lee, Han Jeong Lim, Hyeon-Ji Kim, Yoon Jeon, Hae-Lim Kang, Mi-Ock Lee. Deletion of exons 3 and 4 in the mouse Nr1d1 gene worsens high-fat diet-induced hepatic steatosis. Life Sciences 2016; 166: 13 doi: 10.1016/j.lfs.2016.10.003
|
| 262 |
Benjamin C. T. Bourrie, Tingting Ju, Janelle M. Fouhse, Andrew J. Forgie, Consolato Sergi, Paul D. Cotter, Benjamin P. Willing. Kefir microbial composition is a deciding factor in the physiological impact of kefir in a mouse model of obesity. British Journal of Nutrition 2021; 125(2): 129 doi: 10.1017/S0007114520002743
|
| 263 |
Luisa Vonghia, Nathalie Ruyssers, Dorien Schrijvers, Paul Pelckmans, Peter Michielsen, Luc De Clerck, Albert Ramon, Emilio Jirillo, Didier Ebo, Benedicte De Winter, Chris Bridts, Sven Francque, Jianfei Yang. CD4+RORγt++ and Tregs in a Mouse Model of Diet‐Induced Nonalcoholic Steatohepatitis. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/239623
|
| 264 |
Julien Allard, Dounia Le Guillou, Karima Begriche, Bernard Fromenty. Drug-induced Liver Injury. Advances in Pharmacology 2019; 85: 75 doi: 10.1016/bs.apha.2019.01.003
|
| 265 |
Dawn M. Fedor, Yuriko Adkins, John W. Newman, Bruce E. Mackey, Darshan S. Kelley. The Effect of Docosahexaenoic Acid ont10,c12-Conjugated Linoleic Acid-Induced Changes in Fatty Acid Composition of Mouse Liver, Adipose, and Muscle. Metabolic Syndrome and Related Disorders 2013; 11(1): 63 doi: 10.1089/met.2012.0116
|
| 266 |
Dominika Maciejewska, Agnieszka Łukomska, Karolina Dec, Karolina Skonieczna-Żydecka, Izabela Gutowska, Marta Skórka-Majewicz, Daniel Styburski, Kamila Misiakiewicz-Has, Anna Pilutin, Joanna Palma, Katarzyna Sieletycka, Wojciech Marlicz, Ewa Stachowska. Diet-Induced Rat Model of Gradual Development of Non-Alcoholic Fatty Liver Disease (NAFLD) with Lipopolysaccharides (LPS) Secretion. Diagnostics 2019; 9(4): 205 doi: 10.3390/diagnostics9040205
|
| 267 |
Vadim A. Kosolapov, Roman A. Litvinov, Alexander A. Spasov. Experimental models of fibrosis. Journal of Volgograd State Medical University 2024; 21(3): 39 doi: 10.19163/1994-9480-2024-21-3-39-47
|
| 268 |
Chao Hou, Wenwen Feng, Shan Wei, Yulin Wang, Xiaoyi Xu, Jin Wei, Ziliang Ma, Yongsheng Du, Jialin Guo, Yu He, Fanyun Kong, Renxian Tang, Kuiyang Zheng. Bioinformatics Analysis of Key Differentially Expressed Genes in Nonalcoholic Fatty Liver Disease Mice Models. Gene Expression 2019; 19(1): 25 doi: 10.3727/105221618X15341831737687
|
| 269 |
Seung-Man Yu, Sung Hwan Ki, Hyeon-Man Baek, Zhuoli Zhang. Nonalcoholic Fatty Liver Disease: Correlation of the Liver Parenchyma Fatty Acid with Intravoxel Incoherent Motion MR Imaging–An Experimental Study in a Rat Model. PLOS ONE 2015; 10(10): e0139874 doi: 10.1371/journal.pone.0139874
|
| 270 |
Hyo Won Lee, Tanmay Kumar Pati, In-Jeong Lee, Jeong-Mi Lee, Bo Ra Kim, Sun Young Kwak, Hwan Myung Kim. In Vivo Simultaneous Imaging of Plasma Membrane and Lipid Droplets in Hepatic Steatosis using Red-Emissive Two-Photon Probes. Analytical Chemistry 2022; 94(43): 15100 doi: 10.1021/acs.analchem.2c03285
|
| 271 |
Shota Hori, Hiroshi Hara, Satoshi Ishizuka. Marginal iron deficiency enhances liver triglyceride accumulation in rats fed a high-sucrose diet. Bioscience, Biotechnology, and Biochemistry 2018; 82(12): 2140 doi: 10.1080/09168451.2018.1515616
|
| 272 |
Bart Staels, Anne Rubenstrunk, Benoit Noel, Géraldine Rigou, Philippe Delataille, Lesley J. Millatt, Morgane Baron, Anthony Lucas, Anne Tailleux, Dean W. Hum, Vlad Ratziu, Bertrand Cariou, Rémy Hanf. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology 2013; 58(6): 1941 doi: 10.1002/hep.26461
|
| 273 |
Nada Pejnovic, Ilija Jeftic, Nemanja Jovicic, Nebojsa Arsenijevic, Miodrag L Lukic. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis. World Journal of Gastroenterology 2016; 22(44): 9706-9717 doi: 10.3748/wjg.v22.i44.9706
|
| 274 |
Nikolay P. Sudakov, Igor V. Klimenkov, Mikhail V. Pastukhov. Lake Baikal Endemic Sculpins (Cottoidei): A Promising Model to Study Adaptive Plasticity of Blood Cholesterol Metabolism. Brazilian Archives of Biology and Technology 2015; 58(4): 613 doi: 10.1590/S1516-8913201500054
|
| 275 |
Yuval Ramot, Gil Zandani, Zecharia Madar, Sanket Deshmukh, Abraham Nyska. Utilization of a Deep Learning Algorithm for Microscope-Based Fatty Vacuole Quantification in a Fatty Liver Model in Mice. Toxicologic Pathology 2020; 48(5): 702 doi: 10.1177/0192623320926478
|
| 276 |
S. M. Touhidul Islam, Arun P. Palanisamy, Gabriel R. Chedister, Michael G. Schmidt, David N. B. Lewin, Kenneth D. Chavin, Wan-Long Chuang. Unsaturated or saturated dietary fat-mediated steatosis impairs hepatic regeneration following partial hepatectomy in mice. PLOS ONE 2023; 18(5): e0284428 doi: 10.1371/journal.pone.0284428
|
| 277 |
Tomáš Hammer, Hana Kotolová, Jiří Procházka, Michal Karpíšek. Disruption of Lipid Profile, Glucose Metabolism, and Leptin Levels following Citalopram Administration and High-Carbohydrate and High-Cholesterol Diet in Mice. Pharmacology 2024; : 1 doi: 10.1159/000541229
|
| 278 |
Jianbin Zhang, Daixi Jiang, Shuangzhe Lin, Yuqing Cheng, Jiaxing Pan, Wenjin Ding, Yuanwen Chen, Jiangao Fan. Prolyl endopeptidase disruption reduces hepatic inflammation and oxidative stress in methionine-choline-deficient diet-induced steatohepatitis. Life Sciences 2021; 270: 119131 doi: 10.1016/j.lfs.2021.119131
|
| 279 |
Beibei Liu, Xiaoling Deng, Qianqian Jiang, Guixin Li, Junli Zhang, Ning Zhang, Shengliang Xin, Keshu Xu. Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice. International Immunopharmacology 2019; 75: 105797 doi: 10.1016/j.intimp.2019.105797
|
| 280 |
Hyo Won Lee, In-Jeong Lee, Soo-Jin Lee, Yu Rim Kim, Hwan Myung Kim. Highly Sensitive Two-Photon Lipid Droplet Tracker for In Vivo Screening of Drug Induced Liver Injury. ACS Sensors 2022; 7(4): 1027 doi: 10.1021/acssensors.1c02679
|
| 281 |
Christian Eberhardt, Moritz C. Wurnig, Andrea Wirsching, Cristina Rossi, Markus Rottmar, Pinar S. Özbay, Lukas Filli, Mickael Lesurtel, Andreas Boss. Intravoxel incoherent motion analysis of abdominal organs: computation of reference parameters in a large cohort of C57Bl/6 mice and correlation to microvessel density. Magnetic Resonance Materials in Physics, Biology and Medicine 2016; 29(5): 751 doi: 10.1007/s10334-016-0540-9
|
| 282 |
Eveliina Munukka, Anniina Rintala, Raine Toivonen, Matts Nylund, Baoru Yang, Anna Takanen, Arno Hänninen, Jaana Vuopio, Pentti Huovinen, Sirpa Jalkanen, Satu Pekkala.
Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice. The ISME Journal 2017; 11(7): 1667 doi: 10.1038/ismej.2017.24
|
| 283 |
Rustu Turkay, Abdurrahman Fatih Aydin, Ilknur Bingul, Canan Kucukgergin, Isin Dogan-Ekici, Elif Hocaoglu, Ercan Inci, Baris Bakir, Mujdat Uysal. Can Ultrasound Imaging Predict the Success of an Experimental Steatofibrosis Model?. Ultrasound Quarterly 2017; 33(2): 157 doi: 10.1097/RUQ.0000000000000286
|
| 284 |
Anja Fink, Corinna E. Rüfer, Julie Le Grandois, Alexander Roth, Dalal Aoude-Werner, Eric Marchioni, Achim Bub, Stephan W. Barth. Dietary walnut oil modulates liver steatosis in the obese Zucker rat. European Journal of Nutrition 2014; 53(2): 645 doi: 10.1007/s00394-013-0573-z
|
| 285 |
Sok Kuan Wong, Kok‐Yong Chin, Fairus Ahmad, Soelaiman Ima‐Nirwana. Biochemical and histopathological assessment of liver in a rat model of metabolic syndrome induced by high‐carbohydrate high‐fat diet. Journal of Food Biochemistry 2020; 44(10) doi: 10.1111/jfbc.13371
|
| 286 |
Nikolaos Sikalias, Theodore Karatzas, Konstantinos Alexiou, Lamprini Mountzalia, Maria Demonakou, Ioannis D. Kostakis, Argyro Zacharioudaki, Apostolos Papalois, Gregory Kouraklis. Intermittent Ischemic Preconditioning Protects Against Hepatic Ischemia-Reperfusion Injury and Extensive Hepatectomy in Steatotic Rat Liver. Journal of Investigative Surgery 2018; 31(5): 366 doi: 10.1080/08941939.2017.1334844
|
| 287 |
Jieun Moon, Eunji Kong, Jingu Lee, Jinjoo Jung, Eunha Kim, Seung Bum Park, Pilhan Kim. Intravital longitudinal imaging of hepatic lipid droplet accumulation in a murine model for nonalcoholic fatty liver disease. Biomedical Optics Express 2020; 11(9): 5132 doi: 10.1364/BOE.395890
|
| 288 |
Kyung Eun Kim, Jaewoong Lee, Hyun Joo Shin, Eun Ae Jeong, Hye Min Jang, Yu Jeong Ahn, Hyeong Seok An, Jong Youl Lee, Meong Cheol Shin, Soo Kyoung Kim, Won Gi Yoo, Won Ho Kim, Gu Seob Roh. Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice. Hepatology 2023; 77(3): 888 doi: 10.1002/hep.32569
|
| 289 |
Neil Daniel, Flavia Genua, Mazda Jenab, Ana-Lucia Mayén, Anastasia Chrysovalantou Chatziioannou, Pekka Keski-Rahkonen, David J. Hughes. The role of the gut microbiome in the development of hepatobiliary cancers. Hepatology 2024; 80(5): 1252 doi: 10.1097/HEP.0000000000000406
|
| 290 |
Francesco Faita, Nicole Di Lascio, Chiara Rossi, Claudia Kusmic, Anna Solini. Ultrasonographic Characterization of thedb/dbMouse: An Animal Model of Metabolic Abnormalities. Journal of Diabetes Research 2018; 2018: 1 doi: 10.1155/2018/4561309
|
| 291 |
Shinichi Harada, Kei Miyagi, Tokio Obata, Yasuko Morimoto, Kazuo Nakamoto, Ke Ih Kim, Soo Ki Kim, Soo Ryang Kim, Shogo Tokuyama. Influence of hyperglycemia on liver inflammatory conditions in the early phase of non-alcoholic fatty liver disease in mice. Journal of Pharmacy and Pharmacology 2017; 69(6): 698 doi: 10.1111/jphp.12705
|
| 292 |
Yohei Owada, Takafumi Tamura, Tomohito Tanoi, Yusuke Ozawa, Yoshio Shimizu, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Noriyuki Nakano, Shingo Sakashita, Toshiya Matsukawa, Hiroko Isoda, Nobuhiro Ohkohchi. Novel non‐alcoholic steatohepatitis model with histopathological and insulin‐resistant features. Pathology International 2018; 68(1): 12 doi: 10.1111/pin.12612
|
| 293 |
J.E. Davis, J. Cain, C. Small, D.B. Hales. Therapeutic effect of flax-based diets on fatty liver in aged laying hens. Poultry Science 2016; 95(11): 2624 doi: 10.3382/ps/pew160
|
| 294 |
İlknur Bingül, A. Fatih Aydın, Canan Başaran-Küçükgergin, Işın Doğan-Ekici, Jale Çoban, Semra Doğru-Abbasoğlu, Müjdat Uysal. High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats. International Immunopharmacology 2016; 39: 199 doi: 10.1016/j.intimp.2016.07.028
|
| 295 |
Noha A. El-Boghdady, Maher A. Kamel, Rouaina M. El-Shamy. Omeprazole and Spirulina Platensis Ameliorate Steatohepatitis in Experimental Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 2020; 18(9): 426 doi: 10.1089/met.2019.0129
|
| 296 |
Atsuko Takai, Kentaro Kikuchi, Yusuke Kajiyama, Anna Sugiura, Masatsugu Negishi, Hiromichi Tsunashima, Hanae Yamada, Kotaro Matsumoto, Koichi Tsuneyama, Yuki Moritoki, Masumi Hara, Hiroshi Miyakawa. Serological and Histological Examination of a Nonalcoholic Steatohepatitis Mouse Model Created via the Administration of Monosodium Glutamate. International Scholarly Research Notices 2014; 2014: 1 doi: 10.1155/2014/725351
|
| 297 |
Jie Yan, Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuoyu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker‐Kellogg, Peter T. C. So, Hanry Yu. Development of a classification model for non‐alcoholic steatohepatitis (NASH) using confocal Raman micro‐spectroscopy. Journal of Biophotonics 2017; 10(12): 1703 doi: 10.1002/jbio.201600303
|
| 298 |
Catherine M. Sampson, Andrea L. Dimet, Harshini Neelakantan, Kehinde O. Ogunseye, Heather L. Stevenson, Jonathan D. Hommel, Stanley J. Watowich. Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85051-6
|
| 299 |
Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Kristoffer Tobias Gustav Rigbolt, Kirstine Sloth Tølbøl, Jonathan David Roth, Jacob Jelsing, Niels Vrang, Michael Feigh. Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy. World Journal of Hepatology 2016; 8(16): 673-684 doi: 10.4254/wjh.v8.i16.673
|
| 300 |
Linqiang Zhang, Xiaoyun Wu, Shasha Liao, Yunhai Li, Zhiguo Zhang, Qing Chang, Ruyue Xiao, Bin Liang. Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver disease. Biology Open 2016; 5(10): 1545 doi: 10.1242/bio.020875
|
| 301 |
Dingdong Zhang, Kangle Lu, Guangzhen Jiang, Wenbin Liu, Zaijie Dong, Hongyan Tian, Xiangfei Li. A global transcriptional analysis of Megalobrama amblycephala revealing the molecular determinants of diet-induced hepatic steatosis. Gene 2015; 570(2): 255 doi: 10.1016/j.gene.2015.06.025
|
| 302 |
Lichen Bao, Jun Yin, Wen Gao, Qun Wang, Wenbing Yao, Xiangdong Gao. A long‐acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non‐alcoholic steatohepatitis partly through an FGF21‐adiponectin‐IL17A pathway. British Journal of Pharmacology 2018; 175(16): 3379 doi: 10.1111/bph.14383
|
| 303 |
Shilpi Minocha, Dominic Villeneuve, Viviane Praz, Catherine Moret, Maykel Lopes, Danièle Pinatel, Leonor Rib, Nicolas Guex, Winship Herr. Rapid Recapitulation of Nonalcoholic Steatohepatitis upon Loss of Host Cell Factor 1 Function in Mouse Hepatocytes. Molecular and Cellular Biology 2019; 39(5) doi: 10.1128/MCB.00405-18
|
| 304 |
Giuseppe Musumeci, Francesca Maria Trovato, Rosa Imbesi, Paola Castrogiovanni. Effects of dietary extra-virgin olive oil on oxidative stress resulting from exhaustive exercise in rat skeletal muscle: A morphological study. Acta Histochemica 2014; 116(1): 61 doi: 10.1016/j.acthis.2013.05.006
|
| 305 |
Naoki Harada, Ryo Hanaoka, Hiroko Horiuchi, Tomoya Kitakaze, Takakazu Mitani, Hiroshi Inui, Ryoichi Yamaji. Castration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed mice. Scientific Reports 2016; 6(1) doi: 10.1038/srep23001
|
| 306 |
Luyao Wang, Wenliya Dong, Huan Gao, Chuchu Chen, Siyu Liang, Xianxi Ye, Yi Liu, Yushu Hou, Lei Fan, Tongtong Pan, Zengshou Wang, Yongping Chen, Yongde Luo, Lintao Song. A non-mitogenic FGF4 analog alleviates non-alcoholic steatohepatitis through an AMPK-dependent pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022; 1868(12): 166560 doi: 10.1016/j.bbadis.2022.166560
|
| 307 |
Pradipta Mukherjee, Shinichi Fukuda, Donny Lukmanto, Toshiharu Yamashita, Kosuke Okada, Shuichi Makita, Ibrahim Abd El-Sadek, Arata Miyazawa, Lida Zhu, Rion Morishita, Antonia Lichtenegger, Tetsuro Oshika, Yoshiaki Yasuno. Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography. Biomedical Optics Express 2022; 13(7): 4071 doi: 10.1364/BOE.461433
|
| 308 |
Naoki Harada, Ryo Hanaoka, Kazuki Hanada, Takeshi Izawa, Hiroshi Inui, Ryoichi Yamaji. Hypogonadism alters cecal and fecal microbiota in male mice. Gut Microbes 2016; 7(6): 533 doi: 10.1080/19490976.2016.1239680
|
| 309 |
Michal Pawlak, Eric Baugé, William Bourguet, Karolien De Bosscher, Fanny Lalloyer, Anne Tailleux, Corinna Lebherz, Philippe Lefebvre, Bart Staels. The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice. Hepatology 2014; 60(5): 1593 doi: 10.1002/hep.27297
|
| 310 |
Mara Caputo, Emma Andersson, Ying Xia, Wei Hou, Emmelie Cansby, Max Erikson, Dan Emil Lind, Bengt Hallberg, Manoj Amrutkar, Margit Mahlapuu. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice. International Journal of Molecular Sciences 2024; 25(4): 2446 doi: 10.3390/ijms25042446
|
| 311 |
Daniel Heinrichs, Marie‐Luise Berres, Melanie Coeuru, Meike Knauel, Andreas Nellen, Petra Fischer, Claudia Philippeit, Richard Bucala, Christian Trautwein, Hermann E. Wasmuth, Jürgen Bernhagen. Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis. The FASEB Journal 2014; 28(12): 5136 doi: 10.1096/fj.14-256776
|
| 312 |
Zeynep Madak‐Erdogan, Ping Gong, Yiru Chen Zhao, Liwen Xu, Kinga U. Wrobel, James A. Hartman, Michelle Wang, Anthony Cam, Urszula T. Iwaniec, Russell T. Turner, Nathan C. Twaddle, Daniel R. Doerge, Ikhlas A. Khan, John A. Katzenellenbogen, Benita S. Katzenellenbogen, William G. Helferich. Dietary licorice root supplementation reduces diet‐induced weight gain, lipid deposition, and hepatic steatosis in ovariectomized mice without stimulating reproductive tissues and mammary gland. Molecular Nutrition & Food Research 2016; 60(2): 369 doi: 10.1002/mnfr.201500445
|
| 313 |
Samineh Jafari. Nonvitamin and Nonmineral Nutritional Supplements. 2019; : 37 doi: 10.1016/B978-0-12-812491-8.00005-9
|
| 314 |
Manoj Amrutkar, Urszula Chursa, Matthias Kern, Esther Nuñez‐Durán, Marcus Ståhlman, Silva Sütt, Jan Borén, Bengt R. Johansson, Hanns‐Ulrich Marschall, Matthias Blüher, Margit Mahlapuu. STK25 is a critical determinant in nonalcoholic steatohepatitis. The FASEB Journal 2016; 30(10): 3628 doi: 10.1096/fj.201600562R
|
| 315 |
Ching‐Shu Lai, Sih‐Ning Liao, Mei‐Ling Tsai, Nagabhushanam Kalyanam, Muhammed Majeed, Anju Majeed, Chi‐Tang Ho, Min‐Hsiung Pan. Calebin‐A inhibits adipogenesis and hepatic steatosis in high‐fat diet‐induced obesity via activation of AMPK signaling. Molecular Nutrition & Food Research 2015; 59(10): 1883 doi: 10.1002/mnfr.201400809
|
| 316 |
Jing Chen, Jie Liu, Ye Wang, Xuemei Hu, Feng Zhou, Yimeng Hu, Yin Yuan, Yancheng Xu. Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitro. Biomedicine & Pharmacotherapy 2017; 91: 621 doi: 10.1016/j.biopha.2017.04.125
|
| 317 |
James W. Perfield, Laura C. Ortinau, R. Taylor Pickering, Meghan L. Ruebel, Grace M. Meers, R. Scott Rector. Altered Hepatic Lipid Metabolism Contributes to Nonalcoholic Fatty Liver Disease in Leptin-Deficient Ob/Ob Mice. Journal of Obesity 2013; 2013: 1 doi: 10.1155/2013/296537
|
| 318 |
Donna D. Yu, Gregg Van Citters, Hongzhi Li, Brian M. Stoltz, Barry M. Forman. Discovery of novel modulators for the PPARα (peroxisome proliferator activated receptor α): Potential therapies for nonalcoholic fatty liver disease. Bioorganic & Medicinal Chemistry 2021; 41: 116193 doi: 10.1016/j.bmc.2021.116193
|
| 319 |
Zhiyu Wu. Non-alcoholic Fatty Liver Disease: Pathology, Disease Models and Therapies. Highlights in Science, Engineering and Technology 2023; 36: 347 doi: 10.54097/hset.v36i.5702
|
| 320 |
S Morioka, K Sai, E Omori, Y Ikeda, K Matsumoto, J Ninomiya-Tsuji. TAK1 regulates hepatic lipid homeostasis through SREBP. Oncogene 2016; 35(29): 3829 doi: 10.1038/onc.2015.453
|
| 321 |
Fahrettin Haczeyni, Matthew M Yeh, George N Ioannou, Isabelle A Leclercq, Robert Goldin, Yock Young Dan, Jun Yu, Narcissus C Teoh, Geoffrey C Farrell. Mouse models of non‐alcoholic steatohepatitis: A reflection on recent literature. Journal of Gastroenterology and Hepatology 2018; 33(7): 1312 doi: 10.1111/jgh.14122
|
| 322 |
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology. 2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
|
| 323 |
Steven E. Trasino, Xiao-Han Tang, Jose Jessurun, Lorraine J. Gudas. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease. Journal of Molecular Medicine 2016; 94(10): 1143 doi: 10.1007/s00109-016-1434-z
|
| 324 |
Tomomi Masuya, Miyako Suzuki, Junko Tsujimura, Shinsaku Kanamori, Yuki Miyasaka, Tamio Ohno, Atsushi Murai, Fumihiko Horio, Misato Kobayashi, Hervé Guillou. Ablation of Iah1, a candidate gene for diet-induced fatty liver, does not affect liver lipid accumulation in mice. PLOS ONE 2020; 15(5): e0233087 doi: 10.1371/journal.pone.0233087
|
| 325 |
Nele Boeykens, Peter Ponsaerts, Annemie Van der Linden, Zwi Berneman, Dirk Ysebaert, Kathleen De Greef, Matias A Avila. Injury-Dependent Retention of Intraportally Administered Mesenchymal Stromal Cells Following Partial Hepatectomy of Steatotic Liver Does Not Lead to Improved Liver Recovery. PLoS ONE 2013; 8(7): e69092 doi: 10.1371/journal.pone.0069092
|
| 326 |
Apurva Lad, Robin Su, Joshua Breidenbach, Paul Stemmer, Nicholas Carruthers, Nayeli Sanchez, Fatimah Khalaf, Shungang Zhang, Andrew Kleinhenz, Prabhatchandra Dube, Chrysan Mohammed, Judy Westrick, Erin Crawford, Dilrukshika Palagama, David Baliu-Rodriguez, Dragan Isailovic, Bruce Levison, Nikolai Modyanov, Amira Gohara, Deepak Malhotra, Steven Haller, David Kennedy. Chronic Low Dose Oral Exposure to Microcystin-LR Exacerbates Hepatic Injury in a Murine Model of Non-Alcoholic Fatty Liver Disease. Toxins 2019; 11(9): 486 doi: 10.3390/toxins11090486
|
| 327 |
Li-jun Wang, Hong-wei Zhang, Jing-ya Zhou, Yan Liu, Yang Yang, Xiao-ling Chen, Cui-hong Zhu, Rui-dan Zheng, Wen-hua Ling, Hui-lian Zhu. Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet. The Journal of Nutritional Biochemistry 2014; 25(3): 329 doi: 10.1016/j.jnutbio.2013.11.007
|
| 328 |
Ki-Hoon Park, Zhi-Wei Ye, Jie Zhang, Seok-Hyung Kim. Palmitic Acid-Enriched Diet Induces Hepatic Steatosis and Injury in Adult Zebrafish. Zebrafish 2019; 16(6): 497 doi: 10.1089/zeb.2019.1758
|
| 329 |
|
| 330 |
R. Dangarembizi Dangarembizi, P. Nkomozepi Nkomozepi, R. Ndou Ndou. Type 2 diabetes mellitus-related non-alcoholic steatohepatitis in the Zucker Diabetic Sprague Dawley rat. The Journal of Medical Laboratory Science and Technology of South Africa 2020; 2(2): 89 doi: 10.36303/JMLSTSA.2020.2.2.55
|
| 331 |
Veronica Marin, Natalia Rosso, Matteo Dal Ben, Alan Raseni, Manuela Boschelle, Cristina Degrassi, Ivana Nemeckova, Petr Nachtigal, Claudio Avellini, Claudio Tiribelli, Silvia Gazzin, Anna Alisi. An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. PLOS ONE 2016; 11(7): e0158817 doi: 10.1371/journal.pone.0158817
|
| 332 |
Hanxiang Zhong. Non-alcoholic fatty liver disease: pathogenesis and models. American Journal of Translational Research 2024; 16(2): 387 doi: 10.62347/KMSA5983
|
| 333 |
Yan Liu, Christoph Meyer, Chengfu Xu, Honglei Weng, Claus Hellerbrand, Peter ten Dijke, Steven Dooley. Animal models of chronic liver diseases. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 304(5): G449 doi: 10.1152/ajpgi.00199.2012
|
| 334 |
Naomichi Abe, Sayuka Kato, Takuma Tsuchida, Kanami Sugimoto, Ryuta Saito, Lars Verschuren, Robert Kleemann, Kozo Oka. Longitudinal characterization of diet-induced genetic murine models of nonalcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients. Biology Open 2019; doi: 10.1242/bio.041251
|
| 335 |
Qian Wu, Shuyi Li, Xiaopeng Li, Yong Sui, Yan Yang, Lihong Dong, Bijun Xie, Zhida Sun. Inhibition of Advanced Glycation Endproduct Formation by Lotus Seedpod Oligomeric Procyanidins through RAGE–MAPK Signaling and NF-κB Activation in High-Fat-Diet Rats. Journal of Agricultural and Food Chemistry 2015; 63(31): 6989 doi: 10.1021/acs.jafc.5b01082
|
| 336 |
Irene Pierantonelli, Gianluca Svegliati-Baroni. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. Transplantation 2019; 103(1): e1 doi: 10.1097/TP.0000000000002480
|
| 337 |
Maha Hanafy Mah, Hany Mohamed Ah, Marwa Hanafy Mah, Ibrahim Hassan Bad. Newly Formulated Antioxidant Rich Dietary Supplement in Jelly Form for Alleviation of Liver Diseases in Rats. Journal of Biological Sciences 2017; 17(7): 334 doi: 10.3923/jbs.2017.334.346
|
| 338 |
Esther Nuñez‐Durán, Mariam Aghajan, Manoj Amrutkar, Silva Sütt, Emmelie Cansby, Sheri L. Booten, Andrew Watt, Marcus Ståhlman, Norbert Stefan, Hans‐Ulrich Häring, Harald Staiger, Jan Borén, Hanns‐Ulrich Marschall, Margit Mahlapuu. Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. Hepatology Communications 2018; 2(1): 69 doi: 10.1002/hep4.1128
|
| 339 |
Hui-Jie Liu, Sheng-Tian Cao, Bao-Ying Wen, Xue Han, Yong Li, Shan Li, Jing Li, Lei Zhang. Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/ SCD1 signaling pathway and modulating gut microbiota. International Immunopharmacology 2021; 99: 108065 doi: 10.1016/j.intimp.2021.108065
|
| 340 |
Umakant Ashok Bahirat, Rashmi Talwar, Rekha Raghuveer Shenoy, Kumar V. S. Nemmani, Rajan Naresh Goel. Combination of APD668, a G protein-coupled receptor 119 agonist with linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in a murine model of non-alcoholic steatohepatitis with diabetes. Medical Molecular Morphology 2019; 52(1): 36 doi: 10.1007/s00795-018-0200-4
|
| 341 |
Jieun Moon, Pilhan Kim. Intravital Laser-scanning Two-photon and Confocal Microscopy for Biomedical Research. Medical Lasers 2021; 10(1): 1 doi: 10.25289/ML.2021.10.1.1
|
| 342 |
Agnieszka Kaczor, Katarzyna M. Marzec, Katarzyna Majzner, Kamila Kochan, Marta Z. Pacia, Malgorzata Baranska. Confocal Raman Microscopy. Springer Series in Surface Sciences 2018; 66: 307 doi: 10.1007/978-3-319-75380-5_14
|
| 343 |
Ioannis Katsaros, Maria Sotiropoulou, Michail Vailas, Fotini Papachristou, Paraskevi Papakyriakopoulou, Marirena Grigoriou, Nikolaos Kostomitsopoulos, Alexandra Giatromanolaki, Georgia Valsami, Alexandra Tsaroucha, Dimitrios Schizas. The Effect of Quercetin on Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Beclin1, P62, and LC3: An Experimental Study. Nutrients 2024; 16(24): 4282 doi: 10.3390/nu16244282
|
| 344 |
Milena Vesković, Dušan Mladenović, Marina Milenković, Jelena Tošić, Sunčica Borozan, Milica Labudović Borović, Bojan Jorgačević, Aleksandra Isaković, Vladimir Trajković, Tatjana Radosavljević. THE EFFECTS OF BETAINE ON OXIDATIVE STRESS, INFLAMMATION, APOPTOSIS, AND AUTOPHAGY IN METHIONINE-CHOLINE DEFICIENT DIET-INDUCED FATTY LIVER DISEASE IN MICE. Pathophysiology 2018; 25(3): 233 doi: 10.1016/j.pathophys.2018.07.157
|
| 345 |
Giridhar Kanuri, Ina Bergheim. In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD). International Journal of Molecular Sciences 2013; 14(6): 11963 doi: 10.3390/ijms140611963
|
| 346 |
Yusuke Ozawa, Takafumi Tamura, Yohei Owada, Yoshio Shimizu, Akira Kemmochi, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Hiroko Isoda, Nobuhiro Ohkohchi. Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis. World Journal of Gastroenterology 2018; 24(15): 1622-1631 doi: 10.3748/wjg.v24.i15.1622
|
| 347 |
Hor-Yue Tan, Serban San-Marina, Ning Wang, Ming Hong, Sha Li, Lei Li, Fan Cheung, Xiao-Yan Wen, Yibin Feng, Yoshiji Ohta. Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/4750163
|
| 348 |
Rebeca García‐Román, Rubén Francés. Acetaminophen‐Induced Liver Damage in Hepatic Steatosis. Clinical Pharmacology & Therapeutics 2020; 107(5): 1068 doi: 10.1002/cpt.1701
|
| 349 |
Shi-Xiang Wang, Ji-Song Yan, Yun-Shen Chan. Advancements in MAFLD Modeling with Human Cell and Organoid Models. International Journal of Molecular Sciences 2022; 23(19): 11850 doi: 10.3390/ijms231911850
|
| 350 |
Yan Zhu, Li Chen, Yuqi He, Lin Qin, Daopeng Tan, Zhaojun Bai, Yu Song, Yu-He Wang. The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice. Drug Metabolism Reviews 2023; 55(3): 163 doi: 10.1080/03602532.2023.2202359
|
| 351 |
Martine C. Morrison, Robert Kleemann, Arianne van Koppen, Roeland Hanemaaijer, Lars Verschuren. Key Inflammatory Processes in Human NASH Are Reflected in Ldlr−/−.Leiden Mice: A Translational Gene Profiling Study. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00132
|
| 352 |
Andreas Teufel, Timo Itzel, Wiebke Erhart, Mario Brosch, Xiao Yu Wang, Yong Ook Kim, Witigo von Schönfels, Alexander Herrmann, Stefan Brückner, Felix Stickel, Jean-François Dufour, Triantafyllos Chavakis, Claus Hellerbrand, Rainer Spang, Thorsten Maass, Thomas Becker, Stefan Schreiber, Clemens Schafmayer, Detlef Schuppan, Jochen Hampe. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. Gastroenterology 2016; 151(3): 513 doi: 10.1053/j.gastro.2016.05.051
|
| 353 |
N Di Lascio, C Kusmic, F Stea, F Lenzarini, C Barsanti, A Leloup, F Faita. Longitudinal micro-ultrasound assessment of the ob/ob mouse model: evaluation of cardiovascular, renal and hepatic parameters. International Journal of Obesity 2018; 42(3): 518 doi: 10.1038/ijo.2017.219
|
| 354 |
Jesse D. Riordan, Joseph H. Nadeau. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. Mammalian Genome 2014; 25(9-10): 473 doi: 10.1007/s00335-014-9521-3
|
| 355 |
Chunming Jia, Yi Huan, Shuainan Liu, Shaocong Hou, Sujuan Sun, Caina Li, Quan Liu, Qian Jiang, Yue Wang, Zhufang Shen. Effect of Chronic Pioglitazone Treatment on Hepatic Gene Expression Profile in Obese C57BL/6J Mice. International Journal of Molecular Sciences 2015; 16(6): 12213 doi: 10.3390/ijms160612213
|
| 356 |
Yuling Chi, Dou Yeon Youn, Alus M. Xiaoli, Li Liu, Yunping Qiu, Irwin J. Kurland, Jacob B. Pessin, Fajun Yang, Jeffrey E. Pessin. Comparative impact of dietary carbohydrates on the liver transcriptome in two strains of mice. Physiological Genomics 2021; 53(11): 456 doi: 10.1152/physiolgenomics.00053.2021
|
| 357 |
I. Rodriguez-Ramiro, D. Vauzour, A. M. Minihane. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. Proceedings of the Nutrition Society 2016; 75(1): 47 doi: 10.1017/S0029665115004218
|
| 358 |
Kun Du, Shibo Li, Chengpan Li, Ping Li, Chunguang Miao, Tianzhi Luo, Bensheng Qiu, Weiping Ding. Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supply. Acta Biomaterialia 2021; 134: 228 doi: 10.1016/j.actbio.2021.07.013
|
| 359 |
Teruo Miyazaki, Akira Honda, Tadashi Ikegami, Takashi Iida, Yasushi Matsuzaki. Human-specific dual regulations of FXR-activation for reduction of fatty liver using <i>in vitro</i> cell culture model. Journal of Clinical Biochemistry and Nutrition 2019; 64(2): 112 doi: 10.3164/jcbn.18-80
|
| 360 |
Jihong Ma, Xinping Tan, Yongkook Kwon, Evan R. Delgado, Arman Zarnegar, Marie C. DeFrances, Andrew W. Duncan, Reza Zarnegar. A Novel Humanized Model of NASH and Its Treatment With META4, A Potent Agonist of MET. Cellular and Molecular Gastroenterology and Hepatology 2022; 13(2): 565 doi: 10.1016/j.jcmgh.2021.10.007
|
| 361 |
Qianyun Gan, Ge Song, Wei Fang, Yong Wang, Wentao Qi. Fructose dose-dependently influences colon barrier function by regulation of some main physical, immune, and biological factors in rats. The Journal of Nutritional Biochemistry 2024; 126: 109582 doi: 10.1016/j.jnutbio.2024.109582
|
| 362 |
John D. Clarke, Anika Dzierlenga, Tarana Arman, Erica Toth, Hui Li, Katherine D. Lynch, Dan-Dan Tian, Michael Goedken, Mary F. Paine, Nathan Cherrington. Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity. Toxicon 2019; 162: 1 doi: 10.1016/j.toxicon.2019.03.002
|
| 363 |
Mark A. Febbraio, Saskia Reibe, Shabnam Shalapour, Geraldine J. Ooi, Matthew J. Watt, Michael Karin. Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?. Cell Metabolism 2019; 29(1): 18 doi: 10.1016/j.cmet.2018.10.012
|
| 364 |
Uberdan Guilherme Mendes de Castro, Robson Augusto Souza Augusto Souza dos Santos, Marcelo Eustáquio Silva, Wanderson Geraldo de Lima, Maria José Campagnole-Santos, Andréia Carvalho Alzamora. Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats. Lipids in Health and Disease 2013; 12(1) doi: 10.1186/1476-511X-12-136
|
| 365 |
L. Kořínková, V. Pražienková, L. Černá, A. Karnošová, B. Železná, J. Kuneš, Lenka Maletínská. Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.597583
|
| 366 |
Nesrine Semiane, Fabienne Foufelle, Pascal Ferré, Isabelle Hainault, Souad Ameddah, Aicha Mallek, Ali Khalkhal, Yasmina Dahmani. High carbohydrate diet induces nonalcoholic steato-hepatitis (NASH) in a desert gerbil
. Comptes Rendus. Biologies 2016; 340(1): 25 doi: 10.1016/j.crvi.2016.09.002
|
| 367 |
Zhao Yang, Katherine Roth, Manisha Agarwal, Wanqing Liu, Michael C. Petriello. The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation. The Journal of Nutritional Biochemistry 2021; 95: 108633 doi: 10.1016/j.jnutbio.2021.108633
|
| 368 |
Emmelie Cansby, Esther Nuñez-Durán, Elin Magnusson, Manoj Amrutkar, Sheri L. Booten, Nagaraj M. Kulkarni, L. Thomas Svensson, Jan Borén, Hanns-Ulrich Marschall, Mariam Aghajan, Margit Mahlapuu. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2019; 7(3): 597 doi: 10.1016/j.jcmgh.2018.12.004
|
| 369 |
Di Zhang, Yinghui Zhang, Zhilan Wang, Lei Lei. Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK/mTOR/ULK1‐dependent pathway in nonalcoholic fatty liver disease. Phytotherapy Research 2023; 37(3): 781 doi: 10.1002/ptr.7662
|
| 370 |
Eva-Carina Heier, Anna Meier, Henrike Julich-Haertel, Sonja Djudjaj, Monica Rau, Thomas Tschernig, Andreas Geier, Peter Boor, Frank Lammert, Veronika Lukacs-Kornek. Murine CD103 + dendritic cells protect against steatosis progression towards steatohepatitis. Journal of Hepatology 2017; 66(6): 1241 doi: 10.1016/j.jhep.2017.01.008
|
| 371 |
Chi Ma, Qianfei Zhang, Tim F. Greten. Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes. The FEBS Journal 2018; 285(4): 752 doi: 10.1111/febs.14209
|
| 372 |
Lauren K. Barron, James W. Bao, Bola G. Aladegbami, Jason J. Colasanti, Jun Guo, Christopher R. Erwin, Brad W. Warner. Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis. Journal of Pediatric Surgery 2017; 52(6): 1014 doi: 10.1016/j.jpedsurg.2017.03.026
|
| 373 |
Swati Singh, Anit Kumar, Suruchi Gupta, Rohini Agrawal. Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD). Tissue Barriers 2024; 12(3) doi: 10.1080/21688370.2023.2289830
|
| 374 |
Shiming Jiang, Lindsey Cauthen Minter, Sabrina A. Stratton, Peirong Yang, Hussein A. Abbas, Zeynep Coban Akdemir, Vinod Pant, Sean Post, Mihai Gagea, Richard G. Lee, Guillermina Lozano, Michelle Craig Barton. TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice. Journal of Hepatology 2015; 62(2): 371 doi: 10.1016/j.jhep.2014.09.026
|
| 375 |
Seunghyun Lee, Jae-Hwan Kwak, Sou Hyun Kim, Tae Bin Jeong, Seung Won Son, Joung-Hee Kim, Yong Lim, Joon-Yong Cho, Dae Youn Hwang, Kil Soo Kim, Young-Suk Jung. Comparative study of liver injury induced by high-fat methionine- and choline-deficient diet in ICR mice originating from three different sources. Laboratory Animal Research 2019; 35(1) doi: 10.1186/s42826-019-0016-y
|
| 376 |
Lotte Geys, Elien Roose, Karen Vanhoorelbeke, Pierre Bedossa, Ilse Scroyen, H. Roger Lijnen. Role of ADAMTS13 in diet-induced liver steatosis. Molecular Medicine Reports 2017; 16(2): 1451 doi: 10.3892/mmr.2017.6714
|
| 377 |
Christian Visscher, Lea Middendorf, Ronald Günther, Alexandra Engels, Christof Leibfacher, Henrik Möhle, Kristian Düngelhoef, Stefan Weier, Wolfram Haider, Dimitri Radko. Fat content, fatty acid pattern and iron content in livers of turkeys with hepatic lipidosis. Lipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0484-8
|
| 378 |
Mengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, Dillon C. Gavlock, Richard DeBiasio, Gregory LaRocca, Celeste Reese, Rodrigo M. Florentino, Lanuza A. P. Faccioli, Jacquelyn A. Brown, Lawrence A. Vernetti, Mark Schurdak, Andrew M. Stern, Albert Gough, Jaideep Behari, Alejandro Soto-Gutierrez, D. Lansing Taylor, Mark T. Miedel. Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1423936
|
| 379 |
Yu Jung Heo, Nami Lee, Sung-E. Choi, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Yup Kang, Kwan Woo Lee, Hae Jin Kim, Tomasz Brzozowski. Amphiregulin Induces iNOS and COX-2 Expression through NF-κB and MAPK Signaling in Hepatic Inflammation. Mediators of Inflammation 2023; 2023: 1 doi: 10.1155/2023/2364121
|
| 380 |
Alejandro Garcia-Riv, Violeta M. Madriga, Alejandrina Rodriguez-, Rafael Martinez-M, Margarita L. Martine, Alejandro D. Soriano, Hector R. Galvan-, Rafael Gonzalez-A, Laura L. Valdez-, Francisco Espinoza-G, Oscar A. Newton-, Jose Guzman-Esq, Iram P. Rodrigu, Agustin Lara-Esque, Ivan Delgado-En. A Simple and Low-cost Experimental Mouse Model for the Simultaneous Study of Steatohepatitis and Preclinical Atherosclerosis. Asian Journal of Animal and Veterinary Advances 2014; 9(3): 202 doi: 10.3923/ajava.2014.202.210
|
| 381 |
Yen-Peng Lee, Chien-Chao Chiu, Yung-Chi Chang, Yi-Hsun Chen, Wei-Kai Wu, Ming-Shiang Wu, Hsiao-Li Chuang. Co-exposure to different bacterial species’ lipopolysaccharides with the NASH diet exacerbates NASH and liver fibrosis progression in mice. Clinics and Research in Hepatology and Gastroenterology 2024; 48(9): 102470 doi: 10.1016/j.clinre.2024.102470
|
| 382 |
Erdenetsogt Dungubat, Shiori Watabe, Arisa Togashi-Kumagai, Masato Watanabe, Yasuyuki Kobayashi, Naoki Harada, Ryoichi Yamaji, Toshio Fukusato, Galtsog Lodon, Badamjav Sevjid, Yoshihisa Takahashi. Effects of Caffeine and Chlorogenic Acid on Nonalcoholic Steatohepatitis in Mice Induced by Choline-Deficient, L-Amino Acid-Defined, High-Fat Diet. Nutrients 2020; 12(12): 3886 doi: 10.3390/nu12123886
|
| 383 |
Omar Motiño, Noelia Agra, Rocío Brea Contreras, Marina Domínguez-Moreno, Carmelo García-Monzón, Javier Vargas-Castrillón, Cristina E. Carnovale, Lisardo Boscá, Marta Casado, Rafael Mayoral, M. Pilar Valdecantos, Ángela M. Valverde, Daniel E. Francés, Paloma Martín-Sanz. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2016; 1862(9): 1710 doi: 10.1016/j.bbadis.2016.06.009
|
| 384 |
Leonardo Recena Aydos, Luane Aparecida do Amaral, Roberta Serafim de Souza, Ana Cristina Jacobowski, Elisvânia Freitas dos Santos, Maria Lígia Rodrigues Macedo. Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl/6 Models. Nutrients 2019; 11(12): 3067 doi: 10.3390/nu11123067
|
| 385 |
Komal Thapa, Ajmer Singh Grewal, Neha Kanojia, Lata Rani, Neelam Sharma, Sukhbir Singh. Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development. Current Drug Discovery Technologies 2021; 18(3): 333 doi: 10.2174/1570163817666200121143959
|
| 386 |
Donald B. Jump, Kelli A. Lytle, Christopher M. Depner, Sasmita Tripathy. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacology & Therapeutics 2018; 181: 108 doi: 10.1016/j.pharmthera.2017.07.007
|
| 387 |
Mikhaïl Van Herck, Luisa Vonghia, Sven Francque. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide. Nutrients 2017; 9(10): 1072 doi: 10.3390/nu9101072
|
| 388 |
Yanbo Fan, Haocheng Lu, Yanhong Guo, Tianqing Zhu, Minerva T. Garcia-Barrio, Zhisheng Jiang, Cristen J. Willer, Jifeng Zhang, Y. Eugene Chen. Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice. Gastroenterology 2016; 150(5): 1208 doi: 10.1053/j.gastro.2016.01.005
|
| 389 |
Eun-Ju Cho, Jung-Hwan Yoon, Min-Sun Kwak, Eun Sun Jang, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Chung Yong Kim, Hyo-Suk Lee. Tauroursodeoxycholic Acid Attenuates Progression of Steatohepatitis in Mice Fed a Methionine–Choline-Deficient Diet. Digestive Diseases and Sciences 2014; 59(7): 1461 doi: 10.1007/s10620-014-3217-0
|
| 390 |
Tomoki Kobayashi, Keishi Kanno, Phuong Thao Nguyen, Akiko Sugiyama, Akihiro Kawahara, Yuichiro Otani, Nobusuke Kishikawa, Masanori Ito, Susumu Tazuma. Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology 2020; 35(12): 2140 doi: 10.1111/jgh.15088
|
| 391 |
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(11): 2586 doi: 10.3390/nu11112586
|
| 392 |
Meijian Zhang, Emma Barroso, Maria Ruart, Lucía Peña, Mona Peyman, David Aguilar-Recarte, Marta Montori-Grau, Patricia Rada, Clara Cugat, Carla Montironi, Mohammad Zarei, Javier Jurado-Aguilar, Antoni Camins, Jesús Balsinde, Ángela M. Valverde, Walter Wahli, Xavier Palomer, Manuel Vázquez-Carrera. Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ. Biomedicine & Pharmacotherapy 2023; 167: 115623 doi: 10.1016/j.biopha.2023.115623
|
| 393 |
Shuquan Lv, Zhongyong Zhang, Xiuhai Su, Wendong Li, Xiaoyun Wang, Baochao Pan, Hanzhou Li, Hui Zhang, Yuansong Wang. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway. Frontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1106875
|
| 394 |
Shengtian Cao, Xinye Yang, Zheng Zhang, Junwen Wu, Bo Chi, Hong Chen, Jianghong Yu, Shanshan Feng, Yulin Xu, Jing Li, Yingjun Zhang, Xiaojun Wang, Yan Wang. Discovery of a tricyclic farnesoid X receptor agonist HEC96719, a clinical candidate for treatment of non-alcoholic steatohepatitis. European Journal of Medicinal Chemistry 2022; 230: 114089 doi: 10.1016/j.ejmech.2021.114089
|
| 395 |
Adriana Capucho, Ana Chegão, Fátima Martins, Hugo Vicente Miranda, Sílvia Conde. Dysmetabolism and Neurodegeneration: Trick or Treat?. Nutrients 2022; 14(7): 1425 doi: 10.3390/nu14071425
|
| 396 |
Soufian Lasli, Han‐Jun Kim, KangJu Lee, Ceri‐Anne E. Suurmond, Marcus Goudie, Praveen Bandaru, Wujin Sun, Shiming Zhang, Niyuan Zhang, Samad Ahadian, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. A Human Liver‐on‐a‐Chip Platform for Modeling Nonalcoholic Fatty Liver Disease. Advanced Biosystems 2019; 3(8) doi: 10.1002/adbi.201900104
|
| 397 |
Seyedeh Neda Mousavi, Amirhosein Faghihi, Majid Motaghinejad, Maryam Shiasi, Fatemeh Imanparast, Hamid Lorvand Amiri, Farzad Shidfar. Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet. Biological Trace Element Research 2018; 181(2): 288 doi: 10.1007/s12011-017-1059-2
|
| 398 |
Suriyan Ponnusamy, Quynh T Tran, Thirumagal Thiyagarajan, Duane D Miller, Dave Bridges, Ramesh Narayanan. An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors. Experimental Biology and Medicine 2017; 242(6): 606 doi: 10.1177/1535370216688569
|
| 399 |
Ayumi Eguchi, Sayaka Mizukami, Misato Nakamura, Sousuke Masuda, Hirotada Murayama, Masashi Kawashima, Mari Inohana, Rei Nagahara, Mio Kobayashi, Risako Yamashita, Suzuka Uomoto, Emi Makino, Ryoichi Ohtsuka, Naofumi Takahashi, Shim-Mo Hayashi, Robert R. Maronpot, Makoto Shibutani, Toshinori Yoshida. Metronidazole enhances steatosis-related early-stage hepatocarcinogenesis in high fat diet-fed rats through DNA double-strand breaks and modulation of autophagy. Environmental Science and Pollution Research 2022; 29(1): 779 doi: 10.1007/s11356-021-15689-2
|
| 400 |
Chanbin Lee, Jieun Kim, Youngmi Jung. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Cells 2019; 8(10): 1259 doi: 10.3390/cells8101259
|
| 401 |
Durgesh K. Dwivedi, G. B. Jena. Dimethyl fumarate‐mediated Nrf2/ARE pathway activation and glibenclamide‐mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes‐associated fatty liver in rats by mitigating oxidative stress and inflammation. Journal of Biochemical and Molecular Toxicology 2023; 37(7) doi: 10.1002/jbt.23357
|
| 402 |
Yue Zhao, Tian-Yu Wu, Meng-Fei Zhao, Chao-Jun Li. The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease. Journal of Biological Chemistry 2020; 295(15): 5152 doi: 10.1074/jbc.REV119.008897
|
| 403 |
Hyun Jung Lee, Jong Eun Yeon, Eun Jung Ko, Eileen L Yoon, Sang Jun Suh, Keunhee Kang, Hae Rim Kim, Seoung Hee Kang, Yang Jae Yoo, Jihye Je, Beom Jae Lee, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Kwan Soo Byun. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(45): 12787-12799 doi: 10.3748/wjg.v21.i45.12787
|
| 404 |
Hongxue Li, Qian Xu, Chengye Xu, Yuxin Hu, Xingyang Yu, Kangqi Zhao, Mingqing Li, Meng Li, Junfang Xu, Hongyu Kuang. Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.644129
|
| 405 |
Sara Shojaei Zarghani, Hamid Soraya, Leila Zarei, Mohammad Alizadeh. Comparison of Three Different Diet-Induced Non Alcoholic Fatty Liver Disease Protocols in Rats: A Pilot Study. Pharmaceutical Sciences 2016; 22(1): 9 doi: 10.15171/PS.2016.03
|
| 406 |
Yasushi Horai, Hiroyuki Utsumi, Yuko Ono, Toshimitsu Kishimoto, Yuuichi Ono, Atsushi Fukunari. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non‐alcoholic steatohepatitis model, induced by high‐fat and high‐cholesterol diet. International Journal of Experimental Pathology 2016; 97(1): 75 doi: 10.1111/iep.12169
|
| 407 |
Muhammad Nadeem Aslam, Christine M. Bassis, Li Zhang, Sameer Zaidi, James Varani, Ingrid L. Bergin, Valerio Pazienza. Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles. PLOS ONE 2016; 11(11): e0166178 doi: 10.1371/journal.pone.0166178
|
| 408 |
Gong‐Rak Lee, Hye In Lee, Narae Kim, Jiae Lee, Minjeong Kwon, Ye Hee Kang, Hyeong Ju Song, Chang‐Yeol Yeo, Woojin Jeong. Dynein light chain LC8 alleviates nonalcoholic steatohepatitis by inhibiting NF‐κB signaling and reducing oxidative stress. Journal of Cellular Physiology 2022; 237(9): 3554 doi: 10.1002/jcp.30811
|
| 409 |
Joost Willebrords, Isabel Veloso Alves Pereira, Michaël Maes, Sara Crespo Yanguas, Isabelle Colle, Bert Van Den Bossche, Tereza Cristina Da Silva, Cláudia Pinto Marques Souza de Oliveira, Wellington Andraus, Venâncio Avancini Alves, Bruno Cogliati, Mathieu Vinken. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Progress in Lipid Research 2015; 59: 106 doi: 10.1016/j.plipres.2015.05.002
|